Patent Grant
11298195
The present disclosure relates to the field of medical procedures
Various medical procedures involve the use of one or more scope-type devices configured with certain image-capturing functionality, which may be utilized to provide visualization of certain anatomical features associated with the respective medical procedure. Certain operational processes can be guided at least in part by image data captured using such devices.
Described herein are systems, devices, and methods to facilitate the identification and tracking of various anatomical features based on images of such features obtained using a scope device or other medical instrument. Such feature identification and/or tracking can facilitate the targeting of certain anatomical features in connection with a medical procedure, such as nephroscopy or other procedure accessing the renal anatomy, for example.
In some implementations, the present disclosure relates to a method of positioning a surgical instrument. The method comprises advancing a first medical instrument to a treatment site of a patient, the first medical instrument comprising a camera, recording a target position associated with a target anatomical feature at the treatment site, generating a first image of the treatment site using the camera of the first medical instrument, identifying the target anatomical feature in the first image using a pretrained neural network, and adjusting the target position based at least in part on a position of the identified target anatomical feature in the first image.
The method can further comprise adjusting an orientation of the first medical instrument based at least in part on the position of the identified target anatomical feature in the first image. For example, adjusting the orientation of the first medical instrument can involve centering the identified target anatomical feature in a field of view associated with the camera.
In some embodiments, recording the target position involves contacting the target anatomical feature with a distal end of the first medical instrument, generating position data indicating a contact position of the target anatomical feature and the distal end of the first medical instrument, and causing the position data to be stored in one or more data storage devices. For example, the method can further comprise retracting the distal end of the first medical instrument away from the target anatomical feature prior to said generating the first image.
In some embodiments, the method further comprises generating a second image of the treatment site using the camera of the first medical instrument after generating the first image, identifying an anatomical feature in the second image using the pretrained neural network, determining that the anatomical feature of the second image and the target anatomical feature of the first image represent the same feature, and in response to said determining, adjusting the target position based at least in part on a position of the identified anatomical feature in the second image. For example, determining that the anatomical feature of the second image and the target anatomical feature of the first image represent the same feature can involve determining an amount of overlap between at least a portion of the anatomical feature of the second image and at least a portion of the target anatomical feature of the first image and determining that the amount of overlap is greater than a predetermined threshold. The method may further comprise generating a first mask of the first image that masks the at least a portion of the target anatomical feature of the first image and generating a second mask of the second image that masks the at least a portion of the anatomical feature of the second image, wherein determining the amount of overlap is performed using the first mask and the second mask. In some embodiments, determining that the anatomical feature of the second image and the target anatomical feature of the first image represent the same feature can involve tracking movement of a feature between the first image and the second image. In some embodiments, the method further comprises estimating a three-dimensional position of the anatomical feature of the second image based at least in part on the first image and the second image. For example, estimating the three-dimensional position of the anatomical feature is based on one or more of: camera focal length, camera principal point, relative motion of the first medical instrument, rotation of the first medical instrument, and electromagnetic, structured lighting, and/or time-of-flight sensor readings.
In some embodiments, adjusting the target position is further based at least in part on determined movement of the first medical instrument. The method can further comprise percutaneously directing a second medical instrument through tissue of the patient towards the target position. For example, directing the second medical instrument through the tissue of the patient towards the target position can be performed using sensor data provided by alignment sensors of both the first medical instrument and the second medical instrument. In some embodiments, the method is performed at least in part by a robotic system.
In some implementations, the present disclosure relates to a method of targeting an anatomical feature. The method comprises receiving target position data indicating a target position associated with a target anatomical feature of a patient, storing the target position data in one or more data storage devices, receiving a first image of a surgical site within a patient, using an artificial neural network to identify a first form in the first image that represents the target anatomical feature, and storing updated target position data indicating the target position based on the identified form in the first image.
The method can further comprise causing a medical instrument to be articulated in response to the updated target position data. In some embodiments, the method is performed by control circuitry of a medical system and the target position data and the first image are received from an endoscope of the medical system. The target anatomical feature can be an exposed portion of a papilla within a calyx of a kidney of the patient. The artificial neural network can be pretrained based on known image and label data. For example, the artificial neural network can include a multiple-layer feature pyramid network.
The updated target position data can be based at least in part on known respiratory information relating to the patient. In some embodiments, the method further comprises receiving a second image of the surgical site, using the artificial neural network to identify a second form in the second image that represents the target anatomical feature, and determining a three-dimensional position of the target anatomical feature based at least in part on the first form and the second form. For example, determining the three-dimensional position of the target anatomical feature can be based at least in part on a relative size of the second form. In some embodiments, determining the three-dimensional position of the target anatomical feature is based on data generated by one or more external camera sensors, such as structured lighting sensor(s), time-of-flight sensor(s), and/or the like.
In some implementations, the present disclosure relates to a medical system that comprises an endoscope having a camera and an electromagnetic position sensor associated with a distal end thereof, a robotic medical subsystem including a plurality of articulating arms, and control circuitry communicatively coupled to the endoscope and the robotic medical subsystem. The control circuitry is configured to advance the endoscope to a treatment site of a patient in response to user input, record a position of the distal end of the endoscope within an electromagnetic field, generate user interface data indicating the position as a target anatomical position, receive a first image from the camera of the endoscope, identify a target anatomical feature in the first image using a pretrained neural network, and adjust the target anatomical position based at least in part on a position of the identified target anatomical feature in the first image.
The control circuitry can be further configured to calibrate the distal end of the endoscope in the electromagnetic field. In some embodiments, the medical system further comprises a robotic nephroscope communicatively coupled to the control circuitry.
In some implementations, the present disclosure relates to a computing device comprising an endoscope interface and control circuitry comprising one or more processors and one or more data storage devices. The control circuitry is configured to receive alignment sensor data indicating a position of a distal end of an endoscope coupled to the control circuitry over the endoscope interface, generate first user interface data indicating the position of the distal end of the endoscope as a target nephroscopy position, receive a first image of a medical site over the endoscope interface, identify a first anatomical form in the first image, receive a second image of the medical site over the endoscope interface, identify a second anatomical form in the second image, determine that the first anatomical form and the second anatomical form represent the same target anatomical feature, and update the target nephroscopy position based on said determining.
The control circuitry can be further configured to determine that an amount of overlap of the first form and the second form in an overlay of the first and second images is greater than a predetermined threshold. In some embodiments, the control circuitry is configured to, in response to said updating the target nephroscopy position, generate second user interface data indicating the updated target nephroscopy position.
For purposes of summarizing the disclosure, certain aspects, advantages and novel features have been described. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, the disclosed embodiments may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
Various embodiments are depicted in the accompanying drawings for illustrative purposes and should in no way be interpreted as limiting the scope of the inventions. In addition, various features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure. Throughout the drawings, reference numbers may be reused to indicate correspondence between reference elements.
The headings provided herein are for convenience only and do not necessarily affect the scope or meaning of the claimed invention. Although certain preferred embodiments and examples are disclosed below, inventive subject matter extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and to modifications and equivalents thereof. Thus, the scope of the claims that may arise herefrom is not limited by any of the particular embodiments described below. For example, in any method or process disclosed herein, the acts or operations of the method or process may be performed in any suitable sequence and are not necessarily limited to any particular disclosed sequence. Various operations may be described as multiple discrete operations in turn, in a manner that may be helpful in understanding certain embodiments; however, the order of description should not be construed to imply that these operations are order dependent. Additionally, the structures, systems, and/or devices described herein may be embodied as integrated components or as separate components. For purposes of comparing various embodiments, certain aspects and advantages of these embodiments are described. Not necessarily all such aspects or advantages are achieved by any particular embodiment. Thus, for example, various embodiments may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other aspects or advantages as may also be taught or suggested herein.
Certain standard anatomical terms of location are used herein to refer to the anatomy of animals, and namely humans, with respect to the preferred embodiments. Although certain spatially relative terms, such as “outer,” “inner,” “upper,” “lower,” “below,” “above,” “vertical,” “horizontal,” “top,” “bottom,” and similar terms, are used herein to describe a spatial relationship of one device/element or anatomical structure to another device/element or anatomical structure, it is understood that these terms are used herein for ease of description to describe the positional relationship between element(s)/structures(s), as illustrated in the drawings. It should be understood that spatially relative terms are intended to encompass different orientations of the element(s)/structures(s), in use or operation, in addition to the orientations depicted in the drawings. For example, an element/structure described as “above” another element/structure may represent a position that is below or beside such other element/structure with respect to alternate orientations of the subject patient or element/structure, and vice-versa.
The present disclosure relates to systems, devices, and methods for identifying and tracking target anatomical features of a patient to aid in certain medical procedures. Although certain aspects of the present disclosure are described in detail herein in the context of renal, urological, and/or nephrological procedures, such as kidney stone removal/treatment procedures, it should be understood that such context is provided for convenience and clarity, and anatomical feature identification and tacking concepts disclosed herein are applicable to any suitable medical procedures. However, as mentioned, description of the renal/urinary anatomy and associated medical issues and procedures is presented below to aid in the description of the inventive concepts disclosed herein.
Kidney stone disease, also known as urolithiasis, is a relatively common medical condition involves the formation in the urinary tract of a solid piece of material, referred to as “kidney stones,” “urinary stones,” “renal calculi,” “renal lithiasis,” or “nephrolithiasis.” Urinary stones may be formed and/or found in the kidneys, the ureters, and the bladder (referred to as “bladder stones”). Such urinary stones form as a result of concentrated minerals and can cause significant abdominal pain once they reach a size sufficient to impede urine flow through the ureter or urethra. Urinary stones may be formed from calcium, magnesium, ammonia, ur acid, cysteine, and/or other compounds.
To remove urinary stones from the bladder and ureter, surgeons may a ureteroscope inserted into the urinary tract through the urethra. Typically, a ureteroscope includes an endoscope at its distal end configured to enable visualization of the urinary tract. The ureteroscope can also include a lithotomy mechanism to capture or break apart urinary stones. During a ureteroscopy procedure, one physician/technician may control the position of the ureteroscope, while another other physician/technician may control the lithotomy mechanism.
In order to remove relatively large stones from the kidneys (i.e., “kidney stones”), physicians may use a percutaneous nephrolithotomy (“PCNL”) technique that includes inserting a nephroscope through the skin to break up and/or remove the stone(s). Locating the kidney stone(s) may be achieved using fluoroscopy to provide a target for insertion of the nephroscope. However, fluoroscopy increases the cost of the nephrolithotomy procedure due to the cost of the fluoroscope itself as well as the cost of a technician to operate the fluoroscope. Fluoroscopy also exposes the patient to radiation for a prolonged period of time. Even with fluoroscopy, accurately making a percutaneous incision to access the kidney stone can be difficult and undesirably imprecise. Furthermore, some nephrolithotomy techniques involve a two-day or three-day inpatient stay. In sum, certain nephrolithotomy techniques can be relatively costly and problematic for patients.
According to certain surgical procedures, endoscopes (e.g., ureteroscopes) can be equipped with position sensors, wherein the position of the sensors is used as a target for percutaneous access, such as for PCNL. For example, an electromagnetic-sensor-equipped ureteroscope and/or an electromagnetic-sensor-equipped percutaneous access needle may be used to guide the percutaneous renal access for kidney stone removal and/or the like. In such procedures, the surgeon/physician can drive the ureteroscope to a target calyx of the kidney and use an electromagnetic sensor (e.g., beacon) associated with a distal end/tip of the ureteroscope as the percutaneous access target for the needle. Generally, the efficacy of percutaneous axis to a target calyx can depend at least in part on where the physician positions/parks the ureteroscope with respect to, for example, the position and/or heading of the ureteroscope relative to a papilla through which percutaneous access may be made to the target calyx. For some procedures in which the distal end/tip of the ureteroscope is used as the percutaneous access target, it may be desirable for the distal tip of the ureteroscope to be as close as possible to the papilla/calyx interface during percutaneous access/approximation.
The terms “scope” and “endoscope” are used herein according to their broad and ordinary meanings, and may refer to any type of elongate medical instrument having image generating, viewing, and/or capturing functionality and configured to be introduced into any type of organ, cavity, lumen, chamber, or space of a body. For example, references herein to scopes or endoscopes may refer to a ureteroscope, cystoscope, nephroscope, bronchoscope, arthroscope, colonoscope, laparoscope, borescope, or the like. Scopes/endoscopes, in some instances, may comprise a rigid or flexible tube, and may be dimensioned to be passed within an outer sheath, catheter, introducer, or other lumen-type device, or may be used without such devices.
Robotic-assisted percutaneous procedures can be implemented in connection with various medical procedures, such as kidney stone removal procedures, wherein robotic tools can enable a physician/urologist to perform endoscopic target access (e.g., ureteroscope) as well as percutaneous access or/treatment. However, movements of target anatomical features during operation can be problematic in cases where the operating physician relies on a fixed percutaneous access target position. Advantageously, aspects of the present disclosure relate to real-time target tracking/guidance in medical procedures, which may be utilized by the operating physician to direct a percutandeous-access instrument (e.g., needle or other rigid tool) and/or to guide robotic instrumentation, such as by adjusting endoscope position and/or alignment automatically in response to such real-time target-tracking information. To facilitate such functionality, embodiments of the present disclosure may advantageously provide mechanisms for automatic target detection, tracking, and/or three-dimensional positioned estimation to assist physicians (e.g., urologists) to achieve relatively efficient and accurate percutaneous access for various surgical operations, such as nephroscopy. Although aspects of the present disclosure are described herein for convenience in the context of ureteroscope-guided nephroscopy, it should be understood that inventive aspects of the present disclosure may be implemented in any suitable or desirable type of percutaneous and/or endoscopic medical procedure, whether robotic or not.
Medical System
In some implementations, the system 10 may be used to perform a percutaneous procedure, such as percutaneous nephrolithotomy (PCNL). To illustrate, if the patient 13 has a kidney stone 80 that is too large to be removed through the urinary tract, the physician can perform a procedure to remove the kidney stone through a percutaneous access point on the patient 13. In some embodiments, the physician can interact with the control system 50 and/or the robotic system 11 to control the robotic system 11 to advance and navigate the medical instrument 32 (e.g., a scope) from the urethra 67, through the bladder 65, up the ureter 63, and into the kidney 70 where the stone 80 is located. The control system 50 can provide information via the display 42 regarding the medical instrument 32, such as real-time endoscopic images captured therewith, to assist the physician 5 in navigating the medical instrument.
The renal anatomy is described here for reference with respect to certain medical procedures relating to aspects of the present inventive concepts. The kidneys, shown roughly in typical anatomical position in
The kidneys are typically located relatively high in the abdominal cavity and lie in a retroperitoneal position at a slightly oblique angle. The asymmetry within the abdominal cavity, caused by the position of the liver, typically results in the right kidney being slightly lower and smaller than the left, and being placed slightly more to the middle than the left kidney. On top of each kidney is an adrenal gland. The upper parts of the kidneys are partially protected by the 11th and 12th ribs. Each kidney, with its adrenal gland is surrounded by two layers of fat: the perirenal fat present between renal fascia and renal capsule and pararenal fat superior to the renal fascia.
The kidney participates in the control of the volume of various body fluid compartments, fluid osmolality, acid-base balance, various electrolyte concentrations, and removal of toxins. The kidneys provide filtration functionality by secreting certain substances and reabsorbing others. Examples of substances secreted into the urine are hydrogen, ammonium, potassium and uric acid. In addition, the kidneys also carry out various other functions, such as hormone synthesis, and others.
A recessed area on the concave border of the kidney 70 is the renal hilum 78, where the renal artery (not shown) enters the kidney and the renal vein (not shown) and ureter 63 leave. The kidney is surrounded by tough fibrous tissue, the renal capsule 74, which is itself surrounded by perirenal fat, renal fascia, and pararenal fat. The anterior (front) surface of these tissues is the peritoneum, while the posterior (rear) surface is the transversalis fascia.
The functional substance, or parenchyma, of the kidney is divided into two major structures: the outer renal cortex 77 and the inner renal medulla 87. These structures take the shape of a plurality of cone-shaped renal lobes, each containing renal cortex surrounding a portion of medulla called a renal pyramid 72. Between the renal pyramids 72 are projections of cortex called renal columns 73. Nephrons (not shown in detail in
The tip, or papilla 79, of each pyramid empties urine into a respective minor calyx 75; minor calyces 75 empty into major calyces 76, and major calyces 76 empty into the renal pelvis 71, which transitions to the ureter 63. At the hilum 78, the ureter 63 and renal vein exit the kidney and the renal artery enters. Hilar fat and lymphatic tissue with lymph nodes surrounds these structures. The hilar fat is contiguous with a fat-filled cavity called the renal sinus. The renal sinus collectively contains the renal pelvis and calyces and separates these structures from the renal medullary tissue.
With further reference to the medical system 10, the medical instrument (e.g., scope) 32 can be advanced into the kidney 70 through the urinary tract. Once at the site of the kidney stone 80 (e.g., within a calyx of the kidney 70 through which the stone 80 is accessible), the medical instrument 32 can be used to designate/tag a target location for percutaneous access to the kidney 70. To minimize damage to the kidney and/or surrounding anatomy, the physician 5 can designate a particular papilla 79 of the kidney 70 as the target location for entering into the kidney with a percutandeous-access instrument (e.g., needle; not shown). However, other target locations can be designated or determined. Once the percutandeous-access instrument has reached the target location (e.g., calyx), the utilized percutaneous access path may be used to extract the kidney stone 80 from the patient 13.
In the example of
A scope, such as the scope 32, can be configured to navigate within the human anatomy, such as within a natural orifice or lumen of the human anatomy. A scope can include, for example, a ureteroscope (e.g., for accessing the urinary tract), a laparoscope, a nephroscope (e.g., for accessing the kidneys), a bronchoscope (e.g., for accessing an airway, such as the bronchus), a colonoscope (e.g., for accessing the colon), an arthroscope (e.g., for accessing a joint), a cystoscope (e.g., for accessing the bladder), and so on.
The robotic system 11 can be configured to at least partly facilitate execution of a medical procedure. The robotic system 11 can be arranged in a variety of ways depending on the particular procedure. The robotic system 11 can include one or more robotic arms 12 configured to engage with and/or control the scope 32 to perform a procedure. As shown, each robotic arm 12 can include multiple arm segments coupled to joints, which can provide multiple degrees of movement. In the example of
The robotic system 11 can be coupled to any component of the medical system 100, such as the control system 50, the table 15, the EM field generator (not shown; see
The control system 50 can be configured to provide various functionality to assist in performing a medical procedure. In some embodiments, the control system 50 can be coupled to the robotic system 11 and operate in cooperation with the robotic system 11 to perform a medical procedure on the patient 13. For example, the control system 50 can communicate with the robotic system 11 via a wireless or wired connection (e.g., to control the robotic system 11 and/or the scope 32, receive images captured by the scope 32, etc.), provide fluids to the robotic system 11 via one or more fluid channels, provide power to the robotic system 11 via one or more electrical connections, provide optics to the robotic system 11 via one or more optical fibers or other components, and so on. Further, in some embodiments, the control system 50 can communicate with a needle and/or nephroscope to receive position data therefrom. Moreover, in some embodiments, the control system 50 can communicate with the table 15 to position the table 15 in a particular orientation or otherwise control the table 15. Further, in some embodiments, the control system 50 can communicate with the EM field generator (not shown) to control generation of an EM field in an area around the patient 13.
The control system 50 can include various I/O devices configured to assist the physician 5 or others in performing a medical procedure. For example, the control system 50 can include certain input/output (I/O) components configured to allow for user input to control the scope 32, such as to navigate the scope 32 within the patient 13. in some embodiments, example, the physician 5 can provide input to the control system and/or robotic system, wherein in response, control signals can be sent to the robotic system 11 to manipulate the scope 32. As also shown in
To facilitate the functionality of the control system 50, the control system can include various components (sometimes referred to as “subsystems”). For example, the control system 50 can include control electronics/circuitry, as well as one or more power sources, pneumatic devices, optical sources, actuators, data storage devices, and/or communication interfaces. In some embodiments, the control system 50 includes control circuitry comprising a computer-based control system that is configured to store executable instructions, that when executed, cause various operations to be implemented. In some embodiments, the control system 50 is movable, while in other embodiments, the control system 50 is a substantially stationary system. Although various functionality and components are discussed as being implemented by the control system 50, any of such functionality and/or components can be integrated into and/or performed by other systems and/or devices, such as the robotic system 11, the table 15, for example. Components of an example robotic system are discussed in further detail below in reference to
The medical system 10 can provide a variety of benefits, such as providing guidance to assist a physician in performing a procedure (e.g., instrument tracking, instrument alignment information, etc.), enabling a physician to perform a procedure from an ergonomic position without the need for awkward arm motions and/or positions, enabling a single physician to perform a procedure with one or more medical instruments, avoiding radiation exposure (e.g., associated with fluoroscopy techniques), enabling a procedure to be performed in a single-operative setting, providing continuous suction to remove an object more efficiently (e.g., to remove a kidney stone), and so on. For example, the medical system 10 can provide guidance information to assist a physician in using various medical instruments to access a target anatomical feature while minimizing bleeding and/or damage to anatomy (e.g., critical organs, blood vessels, etc.). Further, the medical system 10 can provide non-radiation-based navigational and/or localization techniques to reduce physician and patient exposure to radiation and/or reduce the amount of equipment in the operating room. Moreover, the medical system 10 can provide functionality that is distributed between at least the control system 50 and the robotic system 11, which may be independently movable. Such distribution of functionality and/or mobility can enable the control system 50 and/or the robotic system 11 to be placed at locations that are optimal for a particular medical procedure, which can maximize working area around the patient, and/or provide an optimized location for a physician to perform a procedure.
The various components of the system 10 can be communicatively coupled to each other over a network, which can include a wireless and/or wired network. Example networks include one or more personal area networks (PANs), local area networks (LANs), wide area networks (WANs), Internet area networks (IANs), cellular networks, the Internet, etc. Furthermore, in some embodiments, the various components of the system 10 can be connected for data communication, fluid/gas exchange, power exchange, and so on via one or more support cables, tubes, or the like.
The column interface 19 can be connected to the column 14 through slots, such as slot 20, that are positioned on opposite sides of the column 14 to guide the vertical translation of the arm support 17. The slot 20 contains a vertical translation interface to position and hold the arm support 17 at various vertical heights relative to the robotic system base 25. Vertical translation of the arm support 17 allows the robotic system 11 to adjust the reach of the robotic arms 12 to meet a variety of table heights, patient sizes, and physician preferences. Similarly, the individually-configurable arm mounts on the arm support 17 allow the robotic arm base 21 of robotic arms 12 to be angled in a variety of configurations.
The robotic arms 12 may generally comprise robotic arm bases 21 and end effectors 22, separated by a series of linkages 23 that are connected by a series of joints 24, each joint comprising one or more independent actuators. Each actuator may comprise an independently-controllable motor. Each independently-controllable joint 24 can provide or represent an independent degree of freedom available to the robotic arm. In some embodiments, each of the arms 12 has seven joints, and thus provides seven degrees of freedom, including “redundant” degrees of freedom. Redundant degrees of freedom allow the robotic arms 12 to position their respective end effectors 22 at a specific position, orientation, and trajectory in space using different linkage positions and joint angles. This allows for the system to position and direct a medical instrument from a desired point in space while allowing the physician to move the arm joints into a clinically advantageous position away from the patient to create greater access, while avoiding arm collisions.
The robotic system base 25 balances the weight of the column 14, arm support 17, and arms 12 over the floor. Accordingly, the robotic system base 25 may house heavier components, such as electronics, motors, power supply, as well as components that selectively enable movement or immobilize the robotic system. For example, the robotic system base 25 includes wheel-shaped casters 28 that allow for the robotic system to easily move around the room prior to a procedure. After reaching the appropriate position, the casters 28 may be immobilized using wheel locks to hold the robotic system 11 in place during the procedure.
Positioned at the upper end of column 14, the console 16 allows for both a user interface for receiving user input and a display screen (or a dual-purpose device such as, for example, a touchscreen 26) to provide the physician user with both pre-operative and intra-operative data. Potential pre-operative data on the touchscreen 26 may include pre-operative plans, navigation and mapping data derived from pre-operative computerized tomography (CT) scans, and/or notes from pre-operative patient interviews. Intra-operative data on display may include optical information provided from the tool, sensor and coordinate information from sensors, as well as vital patient statistics, such as respiration, heart rate, and/or pulse. The console 16 may be positioned and tilted to allow a physician to access the console from the side of the column 14 opposite arm support 17. From this position, the physician may view the console 16, robotic arms 12, and patient while operating the console 16 from behind the robotic system 11. As shown, the console 16 can also include a handle 27 to assist with maneuvering and stabilizing robotic system 11.
The end effector 22 of each of the robotic arms 12 may comprise an instrument device manipulator (IDM), which may be attached using a mechanism changer interface (MCI). In some embodiments, the IDM can be removed and replaced with a different type of IDM, for example, a first type of IDM may manipulate an endoscope, while a second type of IDM may manipulate a laparoscope. The MCI can include connectors to transfer pneumatic pressure, electrical power, electrical signals, and/or optical signals from the robotic arm 12 to the IDM. The IDMs may be configured to manipulate medical instruments (e.g., surgical tools/instruments), such as the scope 32 using techniques including, for example, direct drive, harmonic drive, geared drives, belts and pulleys, magnetic drives, and the like.
The control system 50 shown in
The system 10 may include certain control circuitry 60 configured to perform certain of the functionality described herein. The control circuitry 60 may be part of the robotic system, the control system 50, or both. That is, references herein to control circuitry may refer to circuitry embodied in a robotic system, a control system, or any other component of a medical system, such as the medical system 10 shown in
With further reference to
In some embodiments, at least a portion of the control circuitry 60 is integrated with the robotic system 11 (e.g., in the base 25, column 14, and/or console 14) or another system communicatively coupled to the robotic system 11. In some embodiments, at least a portion of the control circuitry 60 is integrated with the control system 50 (e.g., in the console base 51 and/or display unit 42). Therefore, any description of functional control circuitry herein may be understood to be embodied in either the robotic system 11, the control system 50, or both, and/or at least in part in one or more other local or remote systems/devices.
The system 10 further includes certain user controls 65, which may comprise any type of user input (and/or output) devices or device interfaces, such as one or more buttons, keys, joysticks, handheld controllers (e.g., video-game-type controllers), computer mice, trackpads, trackballs, control pads, and/or sensors (e.g., motion sensors or cameras) that capture hand gestures and finger gestures, and/or interfaces/connectors therefore. The user controls 65 are communicatively and/or physically coupled to at least some of the control circuitry 60.
In some embodiments, the user controls 65 and/or control circuitry 60 are configured to receive user input to allow a user to control a medical instrument, such as an endoscope or nephroscope, such as an instrument manipulatable at least in part by a robotic system, in a velocity mode or position control mode. In velocity mode, the user may be permitted to directly control pitch and yaw motion of a distal end of, for example, an endoscope or other instrument based on direct manual control using the controls 65. For example, movement on a joystick may be mapped to yaw and pitch movement in the distal end of the scope/device. In some embodiments, the user controls 65 are configured to provide haptic feedback to the user. For example, a joystick or other control mechanism may vibrate to indicate an invalid or potentially problematic input. In some embodiments, the control system 50 and/or robotic system 11 can also provide visual feedback (e.g., pop-up messages) and/or audio feedback (e.g., beeping) to indicate issues associated with robotic operation.
In position control mode, the control circuitry 60 may use a three-dimensional (3D) map of a patient and/or pre-determined computer models of the patient to control a medical instrument (e.g., endoscope). For example, the control circuitry 60 can be configured to provide control signals to the robotic arms 12 of the robotic system 11 to manipulate the relevant instrument to position the same at a target location, position, and/or orientation/alignment. For embodiments implementing 3D mapping, position control mode may require sufficiently accurate mapping of the anatomy of the patient.
In some embodiments, a user can manually manipulate a robotic arm 12 of the robotic system 11 without using the user controls 65. For example, during setup in a surgical operating room, a user may move the robotic arms 12 and/or any other medical instruments to provide desired access to a patient. The robotic system 11 may rely on force feedback and inertia control from the user to determine appropriate configuration of the robotic arms 12 and associated instrumentation.
The display device(s) 42 of the control system 50 may be integrated with the user controls 65, for example, as a tablet device with a touchscreen providing for user input. The display device(s) 42 can be configured to provide data and input commands to the robotic system 11 using integrated display touch controls. The display device(s) 42 can be configured to display graphical user interfaces showing information about the position and orientation of various instruments operating within the patient and/or system based on information provided by one or more position sensors. In some embodiments, position sensors associated with medical instruments (e.g., an endoscope) may be configured to generate signals indicative of position and transmit the same on wires and/or transmitters coupled to the sensors. Such connectivity components may be configured to transmit the position information to the console base 51 for processing thereof by the control circuitry 60 and for presentation via the display device(s).
The scope 340 can be articulable, such as with respect to at least a distal portion of the scope, so that the scope can be steered within the human anatomy. In some embodiments, the scope 340 is configured to be articulated with, for example, five degrees of freedom, including XYZ coordinate movement, as well as pitch and yaw. In some embodiments, the needle sensor provides six degrees of freedom, including X, Y, and Z ordinate positions, as well as pitch, law, and yaw. Position sensor(s) of the scope 340 may likewise have similar degrees of freedom with respect to the position information they produce/provide. Figure illustrates multiple degrees of motion of the scope 340 according to some embodiments. As shown in
To capture images at different orientations of the tip 342, a robotic system may be configured to deflect the tip 342 on a positive yaw axis 302, negative yaw axis 303, positive pitch axis 304, negative pitch axis 305, or roll axis 306. The tip 342 or body 345 of the scope 342 may be elongated or translated in the longitudinal axis 306, x-axis 308, or y-axis 309. The scope 340 may include a reference structure (not shown) to calibrate the position of the scope. For example, a robotic system may measure deflection of the scope 340 relative to the reference structure. The reference structure can be located, for example, on a proximal end of the endoscope 340 and may include a key, slot, or flange. The reference structure can be coupled to a first drive mechanism for initial calibration and coupled to a second drive mechanism to perform a surgical procedure.
For robotic implementations, robotic arms of a robotic system can be configured/configurable to manipulate the scope 340 using elongate movement members. The elongate movement members may include one or more pull wires (e.g., pull or push wires), cables, fibers, and/or flexible shafts. For example, the robotic arms may be configured to actuate multiple pull wires (not shown) coupled to the scope 340 to deflect the tip 342 of the scope 118. Pull wires may include any suitable or desirable materials, such as metallic and non-metallic materials such as stainless steel, Kevlar, tungsten, carbon fiber, and the like. In some embodiments, the scope 340 is configured to exhibit nonlinear behavior in response to forces applied by the elongate movement members. The nonlinear behavior may be based on stiffness and compressibility of the scope, as well as variability in slack or stiffness between different elongate movement members.
The scope (e.g., endoscope/ureteroscope) 340 may comprise a tubular and flexible medical instrument that is configured to be inserted into the anatomy of a patient to capture images of the anatomy. In some embodiments, the scope 340 can accommodate wires and/or optical fibers to transfer signals to/from an optical assembly and a distal end 342 of the scope 340, which can include an imaging device 348, such as an optical camera.
The camera/imaging device 348 can be used to capture images of an internal anatomical space, such as a target calyx/papilla of the kidney 70. The scope 340 may further be configured to accommodate optical fibers to carry light from proximately-located light sources, such as light-emitting diodes, to the distal end 342 of the scope. The distal end 342 of the scope 340 can include ports for light sources to illuminate an anatomical space when using the camera/imaging device. In some embodiments, the scope 340 is configured to be controlled by a robotic system similar in one or more respects to the robotic system 11 shown in
For percutaneous nephrolithotomy (PCNL) procedure, access is made into the target calyx through the skin and intervening tissue of the patient. Generally, the preferred access to the calyces of the kidney is through the soft-tissue papilla structures, wherein access through such tissue may be generally associated with reduced risks of bleeding and/or other complications. Where a needle is inserted through a papilla structure, in addition to freedom from bleeding, such pathway can provide full access to the interconnected internal channels (e.g., calyces) of the kidney.
Although PCNL represents a relatively effective method for treating large renal calculi, many physicians choose other procedures due in part to the difficulty of accurately targeting the target papilla/calyx. More particularly, performing a PCNL involves using a needle to gain percutaneous access to a target calyx of the kidney through a patient's flank. This step can be considered extremely important to the ultimate success of the procedure because the physician must select a needle path to the kidney that does not traverse surrounding organs and also allows for a rigid instrument to reach and treat the urinary stone. If the physician fails to do so effectively, they risk causing a visceral or pleural injury or not being able to completely treat the stone. Due to these challenges, the learning curve associated with gaining percutaneous needle access to perform a PCNL a suitable patient position (e.g., the modified supine position) is very high.
In some procedures, the physician(s) study a patient's preoperative computed tomography (CT) images to determine the location of the urinary stone, the location of surrounding organs and bony structures, and examine the morphometry of the calyces. With this knowledge, the physician(s) may mentally generate a pre-operative plan for the percutaneous needle path. Typically, physicians must identify a posterior calyx to puncture to accommodate a rigid instrument. Specifically, a posterior calyx generally provides a relatively straight shot into the renal pelvis. Physicians must try to insert the needle into the kidney through the papilla to avoid damaging renal vasculature and cause bleeding. Intraoperatively, physicians in some procedures rely on fluoroscopy or ultrasound to guide the alignment and insertion of the needle to the target calyx. However, the resolution and interpretation difficulty associated with such imaging techniques can result in a relatively high degree of difficulty in satisfactorily executing the needle puncture. Therefore, embodiments of the present disclosure that provide improved tracking and visualization of target anatomical features, such as papillas and calyces, can improve operational results and appeal to a larger subset of physicians than other PCNL methodologies.
In some embodiments, the medical instrument (e.g., scope) 340 includes a sensor that is configured to generate and/or send sensor position data to another device. The sensor position data can indicate a position and/or orientation of the medical instrument 340 (e.g., the distal end 342 thereof) and/or can be used to determine/infer a position/orientation of the medical instrument. For example, a sensor (sometimes referred to as a “position sensor”) can include an electromagnetic (EM) sensor with a coil of conductive material, or other form/embodiment of an antenna.
In some implementations, as described in further detail below, the distal end of the ureteroscope 340 may be advanced to contact the target anatomical feature (e.g., papilla). With the position sensor associated with the distal end of the scope 340 in contact and/or proximity to the target anatomical feature, the position of the distal end of the scope 340 may be recorded as the target percutaneous access position to which the percutaneous-access instrument (e.g., needle) may be directed to access target calyx through the papilla.
Certain embodiments of the present disclosure advantageously help to automate and guide physicians through the process for gaining percutaneous to target anatomical features. For example, electromagnetic positioning and scope images can be used together to guide the insertion of a needle into a patient. Such solutions can allow non-expert physicians to gain access into the kidney in, for example, the modified supine position and to be able to perform PCNL.
Certain embodiments of the present disclosure involve position-sensor-guided percutaneous access to a target treatment site, such as a target location in the kidney. For example, where the scope 340 is fitted with one or more electromagnetic sensors, and the nehproscope access needle further includes one or more electromagnetic sensors, and such sensors are subjected to the electromagnetic field 90 created by the field generator 315, associated system control circuitry can be configured to detect and track their locations. In some embodiments, the tip of the ureteroscope 340 acts as a guiding beacon while the user inserts the percutaneous access needle. Such solutions can allow the user to hit the target from a variety of approaches, thereby obviating the need to rely on fluoroscopic or ultrasound imaging modalities.
In some embodiments, a control system (not shown in
The scope 340 may be controllable in any suitable or desirable way, either based on user input or automatically. The controls 311, 312 provide examples that may be used to receive user input. In some embodiments, the controls of the scope 340 are located on a proximal handle of the scope, which may be relatively difficult to grasp in some procedural postures/positions as the orientation of the ureteroscope changes. In some embodiments, the scope 340 is controlled using a two-handed controller, as in image 312. Although the controllers 311, 312 are shown as hand-held controllers, user input may be received using any type of I/O device, such as a touchscreen/pad, a mouse, a keyboard, a microphone, etc.
At block 402, the process 400 involves accessing the kidney through the ureter of the patient using a ureteroscope 440, as described above. In particular, the operation of block 402 may involve advancing the scope 440 through the ureter 63, past the renal pelvis 71, and into an area at or near one or more calyces.
At block 404, the process 400 involves locating, using an image-capturing device (e.g. camera) associated with the distal end 442 of the endoscope, a kidney stone 480, for which the patient is to be treated. For example, the kidney stone 480 may be extracted at least in part as an objective of the process 400.
At block 406, the process 400 involves identifying a target papilla 479 that is exposed within a target calyx 475 through which access to the kidney stone 480 may be achieved. Identifying the target papilla 479 may be important for creating a workable tract through which access to the kidney stone 480 can be made via percutaneous access. For example, it may be necessary to determine an angle that is appropriate for access by a relatively rigid nephroscope in such a way as to access a calyx (e.g., minor calyx 475) through which the kidney stone 480 can be reached. In some implementations, it may be desirable or necessary to reach the kidney stone(s) 480 through a posterior calyx in order to provide a sufficiently straight access to the ureteropelvic junction 71. Generally, target minor calyces may be considered relatively small targets. For example, such calyces may be approximately 4-8 mm in diameter. Therefore, precise targeting can be critical in order to effectively extract the kidney stone(s).
The path through which needle/nephroscope access to the target calyx 475 is achieved may advantageously be as straight as possible in order to avoid hitting blood vessels around the renal pyramid 476 associated with the papilla 479 through which the needle/nephroscope may be positioned. Furthermore, the position of various critical anatomy of the patient may necessitate navigation through a constrained window of tissue/anatomy of the patient. For example, the lower pole calyces, below the 12th rib, may provide a suitable access to avoid the pulmonary pleura. Furthermore, the access path may advantageously be medial to the posterior axillary line (e.g. approximately 1 cm below and 1 cm medial to the tip of the 12 rib) to avoid the colon and/or paraspinal muscle. In addition, the access path may advantageously avoid coming within close proximity to the rib to avoid the intercostal nerves. Furthermore, by targeting entry in the area of the axial center of the calyx 475, major arteries and/or other blood vessels can be avoided in some instances.
At block 408, the process 400 involves tagging/recording the position of the exposed papilla 479 within the target calyx 479 through which the desired access is to be achieved. For example, position information/data may be represented/identifiable in a three-dimensional space, such as an electromagnetic field space.
In order to record the position of the papilla 179, the scope 440 may be advanced to physically touch/contact the target papilla 479, as shown by the advanced scope tip 443, in connection with which such contact position may be identified and/or otherwise indicated as the target position by the scope 440 and/or operator. In some implementations, an electromagnetic beacon or other sensor device associated with the distal end/tip 442 of the ureteroscope may indicate the target position, thereby registering the target position in the electromagnetic field space. After contacting/touching the papilla 479 and recording the position, the end 442 of the scope may be retracted, and the depth of such retraction measured in some manner. In some implementations, the operator may be informed that the distal end 443 of the scope 440 has contacted the papilla 479 by monitoring the camera images generated thereby, which may generally become obstructed/blacked-out when contact is made.
At block 410, the process 400 involves percutaneously introducing a medical instrument 450, such as a needle, into the patient. For example, such access may be made via the flank of the patients in some implementations. At block 412, the process 400 involves directing the percutaneously advanced medical instrument 450 towards the target position to ultimately traverse the target papilla 479 and access the target calyx 475 therethrough.
In some embodiments, visual confirmation of the entry of the tip of the needle 450 into the target calyx 475 may be provided by the camera of the scope 440. For example, the scope 440 may be backed-off from the target position, as described above, to thereby provide a field of view including the papilla 479 within the calyx 475, such that the tip of the needle 450 may be seen as it protrudes through the surface of the papilla 479.
With the target location recorded, a percutaneously-inserted medical instrument (e.g., the needle 450) may be directed towards the recorded position. However, where such recorded position is static, anatomical motion occurring after recordation of the target position may result in the target position not accurately reflecting the real-time position associated with the target anatomical feature through which access desired. For example, the act of inserting the needle 450 into the patient may cause certain anatomy around the target organ (e.g., the kidney 70) and/or the target organ itself to migrate and/or become distorted/misshaped in some manner, thereby causing the target anatomical feature (e.g., papilla 479) to assume a position/shape different than at the time at which the target access position was recorded. With respect to renal procedures, the ureteroscope 440 may be fixed to the position of the renal pelvis 71, such that deformation and/or motion of the kidney 70 relative to the ureteroscope may result in such target position corruption. Therefore, the papilla 479 may not be accurately tracked once anatomical motion is introduced into the system.
Once needle access has been made to the calyx 475, a larger-diameter device may be exchanged for the needle 450 to provide a larger port for stone removal. In some implementations, the needle 450 comprises a stylet and a cannula. With the needle tip advanced into the calyx 475, the stylet may be removed, leaving the cannula to form an open port to the location of the kidney stone. Through the cannula, a guide wire may be placed and used to perform the remainder of the process to remove the stone 480. for example, the guide wire can be used to pass a deflated balloon or dilator along the wire. The balloon or dilator can be expanded to create a port large enough introduce a hollow suction tube, such as a nephrostomy tube, directly into the calyx 475. At this point, a nephroscope or any one of a number of other instruments may be introduced into the suction tube to assist in removing the stone 480. For example, a stone breaker, laser, ultrasound, basket, grasper, drainage tube, etc. may be used to remove the stone or fragments thereof, and/or drainage tubes, such as nephrostomy catheters, may be deployed down the suction tube to reduce intra-renal pressure. Any combination of such functionality may be embodied in the nephroscope (not shown) and/or the ureteroscope 440.
Image-Processing-Enhanced Instrument Guidance and Automation
The processes described herein, although described in the context of ureteroscope, may apply to any other type of surgical procedure utilizing a position sensor (e.g., electromagnetic field sensor) and/or camera to track a target anatomical feature, such as a papilla or urinary stone. As described, a static position marker may be registered/recorded to identify a target position associated with a target anatomical feature/landmark. In some embodiments, the present disclosure provides systems, devices, and methods for guiding and/or automating endoscope and/or percutaneous-access instruments based at least in part a static position marker in view of certain target-identification and/or target-tracking image-processing techniques. Target identification and tracking in accordance with embodiments of the present disclosure can apply to any type of robotic endoscopy procedure.
In some implementations, certain image data may be collected and used for identifying target anatomical features. Such identification may be achieved at least in part using a machine learning framework. For example, systems, devices, and methods of the present disclosure may provide for identification of target anatomical features in real-time endoscope images, wherein identification of a target anatomical features in an image may prompt certain responsive action. For example, control circuitry communicatively coupled to robotic endoscopy and/or percutaneous-access device(s) may be configured to track movements of a target feature and take action, such as articulating one or more portions of the endoscope (e.g., distal end portion), or adjusting target position data. For example, the control circuitry may be configured to cause the endoscope to articulate so as to center the target position/points at or near a center of the field of view of an interface and/or image field of the endoscope camera.
By utilizing robotic-assisted percutaneous access, a physician may be able to perform operating target access and treatment. Furthermore, percutaneous access can be further assisted utilizing automated target identification and tracking in accordance with aspects of the present disclosure described in greater detail below, which may be relied upon for accurately maintaining the target position for percutaneous access guidance. Percutaneous access guided by scope-enabled target tracking in accordance with aspects of the present disclosure can be relatively less skill-intensive. In some implementations, a single operator or robotic system may carry out the process. Furthermore, the need for fluoroscopy can be obviated.
Automatic Target Detection
As referenced above, robotic endoscope-guided percutaneous access in accordance with aspects of the present disclosure can utilize location-tracking technology with respect to the target anatomical feature through which access to the treatment site is achieved. For example, position-tracking mechanisms/sensors associated with the distal end of the medical instruments (e.g., scope) and/or a percutaneous-access instrument (e.g., needle) can be implemented in order to guide the physician/technician in aligning the percutaneous-access instruments with the treatment site (e.g., target calyx). Accurate, real-time target tracking, as enabled by aspects of the present disclosure, can enable relatively precise single-stick access to the treatment site.
At block 620, the process 600 involves tagging a position of the target anatomical It is better to clarify that, this manual tagging process is not needed when the image processing approach is able to give the 3D location of the target. For example, tagging the position of the target anatomical position can involve determining and/or recording (e.g., capturing in volatile and/or non-volatile data storage of certain control circuitry as shown and described herein). Tagging the position of the target anatomical feature in connection with block 620 can be performed in any suitable or desirable way, such as using an at least partially manual tagging subprocess 622 or an at least partially image-based tagging subprocess 621, which are described below in connection with blocks 624 and 623, respectively.
With respect to certain manual tagging processes, at block 622, the process 600 involves contacting the target anatomical feature in the treatment site with the distal end of the medical instrument. For example, the medical instrument may comprise a sensor device, such as an electromagnetic sensors/beacon that may indicate a position of the distal end of the medical instrument, and therefore, with the distal end of the medical instrument disposed against and/or adjacent to the target anatomical feature, such position reading can be relied upon as indicating the position of the target anatomical feature. As an example, the user may provide input to notify the relevant computing/medical system of the feature-contact position of the target anatomical feature by tagging/registering the exposed face of the target anatomical feature (e.g., papilla face exposed within the target calyx) in some manner. Such tagging may be implemented through provision of user input in some manner or may be substantially automatic based on perceived tissue contact, or the like.
With respect to certain image-based tagging processes, at block 623, the process 600 involves determining the position of the target anatomical feature using image data input and certain neural network functionality, as described in detail below with respect to
The feature-contact position recorded in connection with the operation(s) of block 620 may be considered a static position with respect to the potentially dynamic relative position of the target anatomical feature, which may change over time. The feature-contact position may be recorded and/or maintained in any suitable or desirable manner, such as stored in one or more data storage devices.
The process 600 proceeds to subprocesses 630, which may involve tracking the target anatomical feature over an operative period of time while advancing percutaneous-access instrument, such as a needle or the like, in the direction of the target anatomical feature. The real-time tracking of the dynamic relative position of the target anatomical feature can advantageously facilitate accurate direction of the percutaneous-access instrument to the treatment site.
The subprocess 630 may be implemented in various ways. For example, as shown as the subprocess 632, live instrument (e.g., scope) tracking may be implemented to provide operational tracking of the target anatomical feature. For example, throughout the relevant operative period, the distal end of the medical instrument may be maintained in contact with the target anatomical feature (block 634), such that position sensor data indicated by the medical instruments may provide a real-time accurate location of the target anatomical feature. Therefore, as shown at block 636, the live position of the medical instrument may be targeted to provide the desired percutaneous access path. However, with the distal end of the medical instrument in close proximity/contact with the target anatomical feature, real-time visualization of the target anatomical feature may not be possible or sufficiently clear due to the obstruction of the target anatomical feature by the feature itself in the field of view of the camera(s). That is, the camera associated with the local instruments may be sufficiently blocked or obscured by the mass of the target anatomical feature, thereby preventing the physician/user from having visual confirmation of penetration of the target anatomical feature by the percutaneous-access instrument (e.g., needle).
An alternative subprocess 631 is shown for tracking the target anatomical feature while still maintaining a clear visual of the target anatomical feature during approximation of the percutaneous-access instrument. Such subprocess 631 may utilize a static tagged position of the target anatomical feature, as in connection with the operation of block 620. For example, at block 633, the subprocess 631 may involve recording the feature contact position associated with the contact with the target anatomical feature implemented in connection with the operation of block 620, described above.
Rather than continuing to maintain the medical instrument in contact/proximity with the target anatomical feature to provide operational tracking, as with subprocess 632, the subprocess 631 may involve retracting the medical instrument a distance away (e.g., in the proximal direction) from the target anatomical feature to thereby allow the medical instrument to clearly capture the target anatomical feature in a field of view of the camera(s) associated therewith as indicated at block 635. For example, in some implementations, the physician/user may inform the system in some manner when the medical instruments has been parked a desired distance away from the target anatomical feature.
By way of clarification, it is noted that the subprocesses 631, 632 represent alternative implementations of the subprocess 630. That is, the process 600 may generally involve implementation of either the subprocess 632 or the subprocess 631, but not both. For example, the subprocess 632 generally illustrates a solution involving leaving a position-tracking device (e.g., electromagnetic beacon) associated with a wire or scope at the position/surface of the target anatomical feature (e.g., papilla), wherein the position-tracking device can be caused/allowed to move with the papilla during needle insertion. The target position, therefore, can be continuously updated as the sensor moves with the target anatomical feature. The subprocess 632 may generally not require/require any real-time image data. However, the solution of subprocess 632 may not provide immediate visual confirmation of needle puncturing of the target papilla due to obstruction.
In some cases, it may be assumed that the scope remains inside of the target calyx and the papilla-to-scope registration is preserved. In the absence of relative movement of the target anatomical feature with respect to the scope position sensor(s), the target position can be continuously updated based on determined current scope position. For example, the operation(s) associated with block 634 may involve, rather than continually maintaining contact between the instrument/sensor and the target anatomical feature, the scope can be retracted away from the target to allow for camera viewing thereof. The position data (e.g., EM data) collected during retraction of the scope can be used to register/record the papilla location with respect to the scope. For example, according to one use case, the retraction/positioning of the scope could be approximately 5 mm in front of the papilla and 2 mm to the left. Such position offset may be used to determine the position of the target as relative to a current position of the scope. However, relative movement between the target anatomical feature and the scope can result in unreliability of the position offset calculation, and therefore, such processes can be inadequate without compensating for relative movement.
In certain respects, the subprocess 631 may represent an improvement compared to the subprocess 632. For example, reliance on static position data and/or scope-offset data may generally not provide a robust solution in and of itself for compensating for anatomical shift with respect to the target anatomical feature and/or other motion, which may be due to, for example, insertion of the percutaneous-access instrument and/or other factors. In addition to anatomical movement, variance in physical positioning of robotic mechanisms and/or other components associated with the driving/positioning of the medical instrument at the treatment site may further introduce inaccuracies with respect to the relative positioning of the target anatomical feature and the distal end of the medical instrument. With undesired movements of the target anatomical feature, the static recorded position thereof may not be confidently relied upon to provide the actual tracking position of the target anatomical feature. Therefore, it may be desirable for the static target position recorded at block 620 to be updated to accommodate anatomical motion and/or other introduced inaccuracies as described above.
With the medical instrument no longer in contact/proximity with the target anatomical feature, the real-time position of the distal end of the medical instrument may therefore not indicate the real-time position of the target anatomical feature in and of itself. Rather, the subprocess 631 may implement various solutions for tracking location of the target anatomical feature based on the static position recorded/tagged in connection with the operation of block 633. For example, at block 637, the subprocess 631 may involve tracking the location of the target anatomical feature by processing real-time image(s) of the target anatomical feature using neural network circuitry and/or other image-tracking functionality implemented by certain system control circuitry in accordance with embodiments of the present disclosure. For example, the neural network and/or other image-tracking mechanism(s) may receive as input real-time image(s) of the target anatomical feature, wherein the neural network circuitry and/or other image-tracking mechanism(s) is/are configured to identify, and determine a position of, the target anatomical feature therein. Such feature-identification functionality may be used to track the target anatomical feature in real-time relative to the static position recorded in connection with block 633.
The subprocess 631 may or may not include/involve the contacting 624 and retracting 635 steps, wherein the user physically contacts the target papilla location and retracts the scope to show the papilla in the field of view of the scope. For example, where image-based tagging 621 is implemented in connection with block 620, it may not be necessary to physically contact the target anatomical feature to determine the position/location thereof. Rather, the position/location may be determined using target-identification mechanisms disclosed herein based on image data captured/generated by one or more cameras of the scope/instrument. For example, in some embodiments, the target is identified and tracked using multiple frames of image/vision and/or position (e.g., EM) data. Examples of such target position determination are described below in connection with
At block 639, the subprocess 631 involves targeting the tracked location of the target anatomical feature with the percutaneous-access instrument. For example, the centroid of an identified papilla shape or form in a real-time image of the treatment site may be used at the target position for a percutaneous-access instrument.
At block 640, the process 600 involves puncturing the target anatomical feature, either without visual confirmation to the target anatomical feature with respect to the subprocess 632 or with visual confirmation in accordance with the subprocess 631, depending on the particular implementation of the process 600.
The various position sensors used in connection with embodiments of the present disclosure, such as for recording the feature-contact position at block 633 or targeting the live instrument position at block 636, may be any type of position sensors. As an example, such sensor(s) may be electromagnetic (EM) sensors/probes. With respect to the scope, the position sensor may be attached or integrated with, proximal to, the tip thereof. Alternatively, the sensor(s) may comprise a coil connected to an electrical wire running the length of the scope, which is connected to external control circuitry configured to interpret electrical signals generated at the coil and passed down the wire. Examples of types of position sensor devices that may be implemented in connection with embodiments of the present disclosure include, but are not limited to, accelerometers, gyroscopes, magnetometers, fiber optic shape sensing (e.g., via Bragg gratings, Rayleigh scattering, interferometry, or related techniques), etc. Depending on the implementation, registration to a separate form of patient imagery, such as a CT scan, may or may not be necessary to provide a frame of reference for locating a urinary stone within the patient.
For reference, certain position determining/localization mechanisms are described that may be implemented in some of the disclosed embodiments. With respect to EM-type sensors, such as coils or other antennas, such sensor devices can be configured detect changes in EM fields as the EM sensor moves within the field (e.g., within the kidney). Therefore, certain embodiments are implemented using one or more EM generators configured to emit EM fields that are picked up by the EM sensor(s). The EM generator(s) may be modulated in any suitable or desirable way, such that when their emitted fields are captured by the EM sensor(s) and are processed by appropriate control circuitry, signals from different EM generators are separable to provide additional dimensions of position information. EM generators may be modulated in time or in frequency, and may use orthogonal modulations so that each signal is fully separable from each other signal despite possibly overlapping in time. Further, separate EM generators may be oriented relative to each other in Cartesian space at non-zero, non-orthogonal angles so that changes in orientation of the EM sensor(s) will result in the EM sensor(s) receiving at least some signal from at least one of the EM generators at any instant in time.
With further reference to the recording of the feature-contact position at block 633 of
The processes disclosed herein may be implemented in connection with procedures other than kidney stone removal procedures, such as gallbladder stone removal, lung (pulmonary/transthoracic) tumor biopsy, and others. Generally, any type of percutaneous procedure may be performed by using an endoscope configured to capture image data for feature identification and tracking using neural network processing in accordance with embodiments of the present disclosure. Additional examples include stomach operations, esophagus and lung operations, etc. Further, the objects to be removed do not necessarily need to be urinary stones, they may be any object, such as a foreign body or object created within the human body.
Neural-Network-Based Anatomical Feature Identification and Tracking
The feature-identification framework 700 may be configured to operate on certain image-type data structures, such as image data representing at least a portion of a treatment site associated with one or more medical procedures. Such input data/data structures may be operated on in some manner by certain transform circuitry 720 associated with an image processing portion of the framework 700. The transform circuitry 720 may comprise any suitable or desirable transform and/or classification architecture, such as any suitable or desirable artificial neural network architecture.
The transform circuitry 720 may be trained according to known anatomical images 712 and target labels 732 corresponding to the respective images 712 as input/output pairs, wherein the transform/classification framework 720 is configured to adjust one or more parameters or weights associated therewith to correlate the known input and output image data. For example, the transform circuitry 720 (e.g., convolutional neural network) may be trained using a labelled dataset and/or machine learning. In some implementations, the machine learning framework may be configured to execute the learning/training in any suitable or desirable manner.
The known target label 732 may be generated at least in part by manually labeling anatomical features in the known anatomical images 712. For example, manual labels may be determined and/or applied by a relevant medical expert to label where, for example, papilla anatomy is among inter-calyx anatomical images. The known input/output pairs can indicate the parameters of the transform circuitry 720, which may be dynamically updatable in some embodiments.
The known target label 732 may depict the boundary and/or the internal area of the target anatomical features present therein. In some embodiments, the framework 700 may be configured to generate the real-time target labels 735 in a manner as to indicate in a binary manner whether a particular image of the real-time anatomical images 715 includes a target anatomical feature or not, wherein further processing may be performed on the images that are identified as containing one or more instances of the target anatomical feature to further identify the location and/or other aspects of the target anatomical feature. In some embodiments, further processing may be performed to determine a three-dimensional location of the identified target anatomical feature and/or one or more portions thereof.
The framework 700 may further be configured to generate real-time target label 735 associated with real-time anatomical images 715 using the trained version of the transform circuitry 720. For example, during a medical procedure, real-time images of the treatment site associated with an endoscope or other medical instrument disposed at a treatment site may be processed using the transform circuitry 720 to generate real-time target labels 735 identifying the presence and/or position of one or more target anatomical features in the real-time images. For example, in some implementations, ureteroscope images may be processed by the transform circuitry 720 to identify the presence, position, and/or shape of a target papilla, which may be targeted with a percutaneous-access instrument as described in detail herein. With respect to ureteroscopic applications, papillary anatomy may generally present similarly in appearance across subjects, and therefore papilla anatomy may be identifiable over a broad demographic.
In some embodiments, the transform circuitry 720 may be configured to identify the target anatomical feature(s) (e.g., papilla), as well as segment-out region(s) that contain the identified anatomical feature(s) and/or enclose the identified anatomical feature(s) in the image. The transform framework 720 may comprise an artificial neural network, such as a convolutional neural network. For example, the framework 720 may implement a deep learning architecture that takes in an input image, assigns learnable weights/biases to various aspects/objects in the image to differentiate one from the other. Filters/characteristics of the framework 720 may be hand-engineered or may be learned through machine learning.
The framework 720 may include a plurality of neurons (e.g., layers of neurons, as shown in
The input to the framework 720 can be video or still images. In some embodiments, the input comprises video, wherein the framework 720 is configured to produce output that indicates how certain features of the video change over (e.g., implementation of a time model). In some implementations, once the neural network 720 has been trained, operational input to the neural network framework can comprise a plurality (e.g., two) of images, wherein the output 735 comprises data indicating the locations of one or more targets across the images (e.g., over time). The input 715 can comprise images or image data, and/or may comprise data indicating differences between separate (e.g., consecutive) images. For example, the framework 720 can detect motion or spatial change between pixels, wherein a change in pixel position indicates motion between images and/or over time. The output can indicate the difference between images. In some embodiments, the neural network framework 720 is trained to estimate optical flow.
The neural network framework 800 may include a pre-trained neural network 821, such as a ResNet 50 neural network, or the like. The framework 800 may further include a feature-extraction component 822 (e.g., feature extraction network (SDN)), such as a feature pyramid network. The feature extraction component 822 may be configured to extract one or more feature maps of an input image and/or engineer feature-detector contours. In embodiments implementing feature pyramid network functionality, multiple images may be processed with different levels of resolution to provide output variants.
The framework 800 may further comprise a region proposal network component 823. The region proposal network 823 may be configured to propose certain bounding boxes on an image that encapsulate targets indicated/identified on feature maps generated and/or provided by the feature extraction component 822.
In some embodiments, a coarse-to-fine processing diagram can be executed to extract the target in an image. Proposed bounding boxes provided by the region proposal network 823 may be used by one or more additional components 827. For example, a binary classification network component 826 may be configured to classify bounding boxes based on whether or not they contain the target feature of interest. Furthermore, a box regression network 825 may be situated and configured to refine boundary boxes proposed by the region proposal network 823. In addition, a mask prediction network component 824 may be configured to calculate and/or represent the silhouette or shape/form of identified target feature(s).
Target Anatomical Feature Tracking
The ability to correctly identify a target anatomical feature, and the position thereof, can advantageously allow for the targeting of the target anatomical feature by a medical instrument during a medical procedure. However, the occurrence of anatomical motion after determination of the target position of the target anatomical feature can cause the target anatomical feature to move away from the known target position. Therefore, embodiments of the present disclosure that provide for the real-time updating of target position data can help obviate issues associated with interoperative anatomical motion.
In some embodiments, a positioning system (e.g., an electromagnetic positioning system as described herein) may be implemented to determine the locations of one or more medical instruments. In some embodiments, the positioning system may be calibrated with camera images to determine the location of features represented in the camera images in the positioning field.
Target anatomical feature tracking can be achieved according to various methodologies. For example, in some embodiments, target tracking can be achieved by comparing the outputs of neural network (or other image processing) circuitry of two consecutively- or sequentially-captured images of the treatment site. For example, given the silhouettes or masks of a target anatomical feature as outputs of a neural network or other type of target-identification circuitry with respect to images captured at different times, the overlap of such silhouettes/masks (e.g., pairwise intersection-over-union (IOU)) such as in the context of percentage of overlap, can be determined. Generally, it may be assumed that the content differences between consecutive images, at least with respect to image capture at a high enough sample rate, do not differ significantly. Therefore, masks of consecutively-captured images can be considered to represent the same target anatomical feature if there overlap percentage is higher than a predefined/predetermined threshold, where the thresholds relates to the maximum movement of targets over the sampling.
At block 904, the process 900 involves receiving a first image of the treatment site from an endoscope or other medical instrument disposed at or near the treatment site. At block 906, the process 900 involves identifying a first feature in the first image using a neural network architecture/framework. For example, the first feature may be a target papilla present at the treatment site. For example, one or more machine learning components or modules may be implemented to perform segmentation of the first feature with respect to the first image.
At block 908, the process 900 involves receiving a second image of the treatment site. The second image may be captured consecutively and/or sequentially with respect to the first image. At block 910, the process 900 involves identifying a second feature in the second image using the neural network. For example, the second feature may be a papilla in a target calyx treatment site. At block 912, the process 900 involves determining that the first and second features represent the same target anatomical feature, such as the same target papilla, at the treatment site. The determination that the first and second features represent the same target anatomical feature may be made in any way, such as by comparing determined overlap or movement of the first and second features and/or portion(s) thereof.
At block 914, the process 900 involves modifying a target tracking position associated with the target anatomical feature based on the identified second feature and/or instrument position data. For example, the instrument position data may correspond to an initial tagged position of the medical instrument and/or an articulation or relative movement thereof. Modification of the target tracking position may serve to track the target anatomical feature by compensating for dynamic relative movement thereof. Furthermore, an endoscope or other medical instrument used to capture the first image and the second image may have an electromagnetic sensor or other position sensor associated therewith. Such position sensor may be used to introduce compensation for movement of the medical instrument to the target tracking position data.
Modification of the target tracking position may be necessitated and/or desirable based on relative motion of the target anatomical feature between the time of capture of the first image and the time of capture of the second image. As described above, such motion may be caused by the insertion and/or manipulation of a percutaneous-access instrument, such as a needle, in the general area of the treatment site. Because of the motion, the target anatomical feature (e.g., papilla) may generally not stay fixed with respect to the scope, which may be used to determine the initial target position. Therefore, feature identification and tracking functionality disclosed in connection with systems, devices, and methods of the present disclosure may allow for tracking of the target anatomical feature over time using camera images. Such tracking may be used to predict the three-dimensional location of the target anatomical feature dynamically, wherein the three-dimensional location may be used as the target tracking position for a percutaneous-access instrument, as described herein. Achieving rendezvous between the percutaneous-access instrument and the target anatomical feature may be greatly aided by the dynamic target estimation, as described herein.
The position of the camera of the medical instrument (e.g., endoscope) may be determined in relation to the position of the position sensor associated with the distal end of medical instrument. With such camera position information, the location of an object/feature appearing in image space may be determined with respect to the position space associated with the position sensor (e.g., electromagnetic field space). Therefore, the position of the second feature in the second image may be determined in three-dimensional space and can be provided for direction of the percutaneous-access instrument (e.g., needle).
Although
Neural network and masking concepts disclosed herein can be implemented in accordance with aspects of the publication “Mask R-CNN,” (He, Kaiming, Georgia Gkioxari, Piotr Dollár, and Ross Girshick. “Mask r-cnn.” In Computer Vision (ICCV), 2017 IEEE International Conference on, pp. 2980-2988. IEEE, 2017), the entire contents of which are hereby expressly incorporated by reference.
At block 1002, the process 1000 involves generating a target mask 122 for a first image 121 of the treatment site taken at a first time (t). As shown in the image 121, the first image includes at least a portion of a target anatomical feature 111, which may represent a papilla visible from within a calyx/kidney treatment site. The image 122 represents a mask of the target anatomical feature. Although any mask may be used in accordance with embodiments of the present disclosure, the illustrated mask 122 is a binary mask including a feature area 112 representing a shape or form of the visible portion of the target anatomical feature 111, and a background portion 119 representing the area of the image 121 that does not correspond to the target anatomical feature 111. The mask 122 may be generated using any type of segmentation and/or machine learning mechanism, with the segmented regions bifurcated to provide a region mask, as shown.
At block 1004, the process 1000 involves generating a target mask 124 for a second image 123 taken the time (t+1) that is subsequent to the time (t) when the first image 121 was captured. Through neural network image processing, or other target-identification mechanism in accordance with aspects of the present disclosure, the target anatomical feature 113 may be identified in the image 123. The mask 124 of the image 123 with respect to the target feature 113 is shown as the image 124, which includes a feature area 114 representing a shape/silhouette or form of the visible portion of the target anatomical feature 113 and the image 123 and a background portion 127 representing the area of the image 123 that does not correspond to the target anatomical feature 113.
At block 1006, the process 1000 involves determining target or feature overlap in the first 121 and second 123 images using the respective masks 122, 124 thereof. The image 125 represents an overlay of the first mask 122 and the second mask 124. The resulting image 125 includes a portion 115 that corresponds to background for both the first image 121 and the second image 123, a portion 116, which corresponds to background with respect to the first image 121 but feature area with respect to the second image 123, and a portion 117, which corresponds to background with respect to the second image 123 but feature area with respect to the first image 121. The remaining area 118 represents an area of overlap between the identified anatomical features 111, 113. The overlap area/shape is shown separately as image 126 for clarity and represents an area not greater than either of the feature areas of the masks 122, 124.
The process 1000 may proceed to decision block 1008, where it may be determined whether the amount of overlap 118, 126 is greater than a predetermined threshold amount of overlap with respect to the area of the first feature area 112, the second feature area 114, or both. If the determination is in the affirmative, the process 1000 proceeds to block 1010, wherein a responsive action may be taken. For example, at block 1010, it may be assumed that the first identified anatomical feature 111 and the second identified anatomical feature 113 represent the same target anatomical feature. For example, both identified features may represent the same papilla within the kidney of a patient. Therefore, any change in position between the images 121 and 123 may represent anatomical movement, and therefore responsive action may involve adjusting a target position associated with the target anatomical feature and/or adjusting a position of a medical instrument being utilized, such as the instrument utilized to capture the images 121, 123 (e.g., an endoscope and/or camera thereof). For example, one or more robotic arms may be configured to respond by adjusting the arm(s) and/or an endoscope position controlled by the robotic arm(s). Determination of overlap of the relevant regions may be based on two-dimensional X/Y axes. Although the difference between the images 121, 123 is described as being attributed to the anatomical movement, it should be understood that such differences may be attributable at least in part to movements of one or more operational tools or instruments.
If the feature overlap does not meet the predetermined threshold, the process 1000 may proceed to block 1012, which may or may not be associated with any responsive action. For example, at block 1012, it may be assumed that the features 111, 113 represent separate anatomical features and/or portions thereof. Therefore, the differences in position between the features 111, 113 may not be relied upon as representing particular anatomical movement of a target anatomical feature. In some embodiments, the predetermined threshold may be dynamically tunable, and may be selected and/or determined to produce desirable or optimal differentiating performance. For example, the threshold may be determined based on analysis of prior known data, as described herein. In some embodiments, movements that can be attributed to cyclical respiratory action may be filtered out, such that such movement is not attributed to movements of the target anatomical feature. For example, the sampling of the images 121, 123 may be performed such that they correspond to similar points in the period of the respiratory cycle. In some implementations, the images are sampled at approximately 30 frames per second, or any other suitable or desirable sampling rate.
In addition to direct tracking methods as described above, indirect tracking methods may be implemented in accordance with the present disclosure. For example, optical flow tracking may be implemented in order to track the movements of target anatomical feature portions and/or corresponding pixel representations thereof across multiple images. For example, tracking pixels representative of a common image feature may provide target anatomical feature movement information. Furthermore, other feature-tracking mechanisms may be implemented, such as tracking of corners, blogs, pixel groups, and/or any other image features.
Although segmentation/masking can be performed using image processing methodologies as described herein, including neural network frameworks and the like, in some implementations, segmentation/masking is performed at least partially manually by the physician or other technician/operator. For example, the technician may select the target anatomical feature and identify similar features in subsequent image(s), wherein the movement represented by the sequential feature identification/segmentation can be accounted for in any suitable or desirable manner in accordance with presents disclosure. In some implementations, feature descriptors may be run locally in the identified feature area, which may be considered an area in which there is a high likelihood of feature presence in subsequent images.
Although aspects of the present inventive disclosure are presented in the context of ureteroscope, it should be understood that such concepts are applicable to any type of endoscopy application. For example, the feature identification and tracking techniques described herein may be utilized for the purpose of identifying and tracking polyps or other target anatomical features. With respect to bronchoscopy procedures, target anatomical feature identification and tracking concepts of the present disclosure may be utilized to identify tumors and/or manage scope position for the purpose of collecting samples or the like. With respect to respiratory procedures, feature identification and targeting accordance with the present disclosure may be utilized to identify and/or track nodules inside the target airway, airways themselves, and/or other features.
With respect to any of the embodiments disclosed herein, it should be understood that known scope movement data may be compensated for with respect to target anatomical feature identification and/or tracking. Furthermore, position sensor information may further provide information indicating movement for which compensation may be made for target feature tracking purposes. With further reference to
With respect to the various embodiments disclosed herein, position information may be determined and/or generated using any suitable or desirable type of sensor, device, or combination thereof. For example, position sensors/devices of the present disclosure may include one or more of any of the following: electromagnetic sensors, impedance spectroscopy sensors, coaxial sensors, inertial measurement sensors, accelerometers, magnetic meters, gyroscopes, and/or any other type of sensor providing information indicating a position, distance, orientation, acceleration, alignment, or the like.
Three-Dimensional Target Position Estimation
Three-dimensional (3D) position estimation for the purpose of target anatomical feature tracking in accordance with aspects of the present disclosure may be implemented according to any suitable or desirable technique or mechanism. For example, in some embodiments, distance between an endoscope camera and a target anatomical feature may be estimated based on the representative size of the anatomical feature in an image.
In some embodiments, information relating to angle of movement of a scope and/or anatomical feature may be used to determine 3D position. For example, electromagnetic sensors/beacons in an electromagnetic field/space can provide such angle of movement information. By combining electromagnetic sensor data with image data, mappings between distance from the target anatomical feature and size of the target anatomical feature in a resulting image captured after the movement of such distance can be used to estimate depth/distance of features in subsequent images. In some embodiments, when contacting the target anatomical feature (e.g., a papilla) and retracting the scope away from such feature to park the scope in a position to provide a desirable field of view, the distance traveled may be registered using, for example, electromagnetic sensor data. Furthermore, subsequent images and provide information relating to how large the anatomical feature appears in such images, and therefore the relationship/mapping between feature size and distance can be determined and used for future position determination. In some implementations, machine learning may be utilized to classify images and determine position information based on the size of features in such images.
In some embodiments, machine learning may be utilized to train a neural network framework to interpret image data and produce output indicating 3D depth of image pixels. Such machine learning may be implemented according to any suitable or desirable process or mechanism described herein. In some embodiments, external camera sensor(s) associated with medical instruments (e.g., scopes) can be utilized to obtain the 3D location of the target. For example, structured-lighting sensor(s) and/or time-of-flight sensor(s) can be used in determination of 3D positioning.
According to some embodiments, a geometric translation approach may be implemented to detect the 3D position of a target anatomical feature. For example, as with certain other embodiments of the present disclosure, potential images may be captured that are associated with separate timestamps. In connection with such images, rotational translation information with respect to the camera, which may be determined based on sensor information from any suitable or desirable sensor or device, may be used to triangulate and/or determine the positions of such images in 3D space, thereby providing information indicating 3D location of target anatomical feature(s) in the 3D space. The rotational translation information may be based on robotic actuator movement and/or position sensor information, such as from an electromagnetic beacon device associated with the camera and/or scope and indicating a position of the camera in the electromagnetic field space.
Given the intrinsic and extrinsic parameters (principle points, focal length and distortion factors, relative motion) of the camera, we can then calculate the 3D location of the target anatomical feature based at least in part on the tracked target two-dimensional (2D) locations on the images. For intrinsic parameters, the camera principle point and focal length may be accounted for. Additional data that may be taken into account may include radial and tangential distortion factors. Based on the sensor readings (e.g., either robotic- or EM-based), extrinsic parameters may also be obtained, including rotation R and translation T of the scope between the locations where the two images were taken. For convenience, K may be denoted as a matrix that contains the intrinsic parameters and H denoted as a 4-by-4 matrix that contains the extrinsic rotation and translation between Ct and Ct+1.
For Ct, the 3D-to-2D projection relationship can be expressed as xt=KX, where X is the 3D coordinate w.r.t. Ct and xt is the 2D coordinate (detected centroid of a target) on image t. Here, K is a three-by-4 matrix that can be expressed as:
with K(n) being the n-th row in K.
Similarly, for Ct+1, xt+1=K′X, where:
As xt and KX are parallel vectors, xt×KX=0, and similarly, xt+1×K′X=0. Here, ‘×’ is the cross-product operator. Hence:
The above may produce: i(vtK(3)X−K(2)X)−j(utK(3)X−K(1)X)+k(utK(2)X−vtK(1)X)=0, where ut and vt are the 2D coordinates of xt. Hence:
vtK(3)X−K(z)X=0
utK(3)X−K(1)X=0
utK(2)X−vtK(1)X=0
Here, only the first two equations may be needed, as the third equation is a linear combination of the first two. Similarly, for Ct+1, the following two equations can be obtained:
vt+1K′(3)X−K′(2)X=0
ut+1K′(3)X−K′(1)X=0
After stacking the equations of Ct and Ct+1, the following may be produced:
AX=0,
where A is 4-by-4 matrix:
As the elements in A are known (detected 2D coordinates, intrinsic and extrinsic parameters), X can be calculated by performing singular value decomposition (SVD) on A:
A=UΣVT,
and the last column of V is the solution of X.
Therefore, in view of the foregoing disclosure, the various inventive concepts disclosed herein may be utilized to perform automatic target detection, target tracking, and/or three-dimensional position estimation. In some embodiments, aspects of the present disclosure advantageously allow for target anatomical feature tracking without requiring physical contact with the target anatomical feature, which may facilitate improved ergonomics of the usage of the ureteroscope.
Control circuitry configured to implement the system of
Depending on the embodiment, certain acts, events, or functions of any of the processes or algorithms described herein can be performed in a different sequence, may be added, merged, or left out altogether. Thus, in certain embodiments, not all described acts or events are necessary for the practice of the processes.
Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is intended in its ordinary sense and is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous, are used in their ordinary sense, and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Conjunctive language such as the phrase “at least one of X, Y and Z,” unless specifically stated otherwise, is understood with the context as used in general to convey that an item, term, element, etc. may be either X, Y or Z. Thus, such conjunctive language is not generally intended to imply that certain embodiments require at least one of X, at least one of Y and at least one of Z to each be present.
It should be appreciated that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, Figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of one or more of the various inventive aspects. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Moreover, any components, features, or steps illustrated and/or described in a particular embodiment herein can be applied to or used with any other embodiment(s). Further, no component, feature, step, or group of components, features, or steps are necessary or indispensable for each embodiment. Thus, it is intended that the scope of the inventions herein disclosed and claimed below should not be limited by the particular embodiments described above, but should be determined only by a fair reading of the claims that follow.
It should be understood that certain ordinal terms (e.g., “first” or “second”) may be provided for ease of reference and do not necessarily imply physical characteristics or ordering. Therefore, as used herein, an ordinal term (e.g., “first,” “second,” “third,” etc.) used to modify an element, such as a structure, a component, an operation, etc., does not necessarily indicate priority or order of the element with respect to any other element, but rather may generally distinguish the element from another element having a similar or identical name (but for use of the ordinal term). In addition, as used herein, indefinite articles (“a” and “an”) may indicate “one or more” rather than “one.” Further, an operation performed “based on” a condition or event may also be performed based on one or more other conditions or events not explicitly recited.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which example embodiments belong. It be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
The spatially relative terms “outer,” “inner,” “upper,” “lower,” “below,” “above,” “vertical,” “horizontal,” and similar terms, may be used herein for ease of description to describe the relations between one element or component and another element or component as illustrated in the drawings. It be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation, in addition to the orientation depicted in the drawings. For example, in the case where a device shown in the drawing is turned over, the device positioned “below” or “beneath” another device may be placed “above” another device. Accordingly, the illustrative term “below” may include both the lower and upper positions. The device may also be oriented in the other direction, and thus the spatially relative terms may be interpreted differently depending on the orientations.
Unless otherwise expressly stated, comparative and/or quantitative terms, such as “less,” “more,” “greater,” and the like, are intended to encompass the concepts of equality. For example, “less” can mean not only “less” in the strictest mathematical sense, but also, “less than or equal to.”
This application claims priority to U.S. Provisional Application No. 62/955,991, filed Dec. 31, 2019, and entitled ANATOMICAL FEATURE IDENTIFICATION AND TARGETING, the disclosure of which is hereby incorporated by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 4644237 | Frushour et al. | Feb 1987 | A |
| 4745908 | Wardle | May 1988 | A |
| 4748969 | Wardle | Jun 1988 | A |
| 5194791 | Cull | Mar 1993 | A |
| 5199417 | Muller et al. | Apr 1993 | A |
| 5251611 | Zehel et al. | Oct 1993 | A |
| 5273025 | Sakiyama et al. | Dec 1993 | A |
| 5280781 | Oku | Jan 1994 | A |
| 5408263 | Kikuchi et al. | Apr 1995 | A |
| 5526812 | Dumoulin et al. | Jun 1996 | A |
| 5550953 | Seraji | Aug 1996 | A |
| 5669876 | Schechter et al. | Sep 1997 | A |
| 5672877 | Liebig et al. | Sep 1997 | A |
| 5769086 | Ritchart et al. | Jun 1998 | A |
| 5831614 | Tognazzini et al. | Nov 1998 | A |
| 5876325 | Mizuno et al. | Mar 1999 | A |
| 5899851 | Koninckx | May 1999 | A |
| 5935075 | Casscells et al. | Aug 1999 | A |
| 6004016 | Spector | Dec 1999 | A |
| 6038467 | Bliek et al. | Mar 2000 | A |
| 6047080 | Chen et al. | Apr 2000 | A |
| 6059718 | Taniguchi et al. | May 2000 | A |
| 6063095 | Wang et al. | May 2000 | A |
| 6167292 | Badano et al. | Dec 2000 | A |
| 6198974 | Webster, Jr. | Mar 2001 | B1 |
| 6203493 | Ben-Haim | Mar 2001 | B1 |
| 6246200 | Blumenkranz et al. | Jun 2001 | B1 |
| 6246784 | Summers et al. | Jun 2001 | B1 |
| 6246898 | Vesely et al. | Jun 2001 | B1 |
| 6332089 | Acker et al. | Dec 2001 | B1 |
| 6425865 | Salcudean et al. | Jul 2002 | B1 |
| 6459926 | Nowlin et al. | Oct 2002 | B1 |
| 6466198 | Feinstein | Oct 2002 | B1 |
| 6490467 | Bucholz et al. | Dec 2002 | B1 |
| 6553251 | Lähdesmäki | Apr 2003 | B1 |
| 6665554 | Charles et al. | Dec 2003 | B1 |
| 6690963 | Ben-Haim et al. | Feb 2004 | B2 |
| 6690964 | Bieger et al. | Feb 2004 | B2 |
| 6755797 | Stouffer | Jun 2004 | B1 |
| 6812842 | Dimmer | Nov 2004 | B2 |
| 6837846 | Jaffe et al. | Jan 2005 | B2 |
| 6899672 | Chin et al. | May 2005 | B2 |
| 6926709 | Bieger et al. | Aug 2005 | B2 |
| 7180976 | Wink et al. | Feb 2007 | B2 |
| 7197354 | Sobe | Mar 2007 | B2 |
| 7206627 | Abovitz et al. | Apr 2007 | B2 |
| 7233820 | Gilboa | Jun 2007 | B2 |
| 7386339 | Strommer et al. | Jun 2008 | B2 |
| 7607440 | Coste-Maniere et al. | Oct 2009 | B2 |
| 7756563 | Higgins et al. | Jul 2010 | B2 |
| 7763015 | Cooper et al. | Jul 2010 | B2 |
| 7772541 | Froggatt et al. | Aug 2010 | B2 |
| 7850642 | Moll et al. | Dec 2010 | B2 |
| 7901348 | Soper et al. | Mar 2011 | B2 |
| 7963288 | Rosenberg et al. | Jun 2011 | B2 |
| 8021326 | Moll et al. | Sep 2011 | B2 |
| 8155403 | Tschirren et al. | Apr 2012 | B2 |
| 8190238 | Moll et al. | May 2012 | B2 |
| 8298135 | Ito et al. | Oct 2012 | B2 |
| 8317746 | Sewell et al. | Nov 2012 | B2 |
| 8335557 | Maschke | Dec 2012 | B2 |
| 8348931 | Cooper et al. | Jan 2013 | B2 |
| 8376934 | Takahashi et al. | Feb 2013 | B2 |
| 8394054 | Wallace et al. | Mar 2013 | B2 |
| 8396595 | Dariush | Mar 2013 | B2 |
| 8442618 | Strommer et al. | May 2013 | B2 |
| 8460236 | Roelle et al. | Jun 2013 | B2 |
| 8469945 | Schena | Jun 2013 | B2 |
| 8498691 | Moll et al. | Jul 2013 | B2 |
| 8506555 | Morales | Aug 2013 | B2 |
| 8554368 | Fielding et al. | Oct 2013 | B2 |
| 8652030 | Matsuura et al. | Feb 2014 | B2 |
| 8720448 | Reis et al. | May 2014 | B2 |
| 8738181 | Greer et al. | May 2014 | B2 |
| 8821376 | Tolkowsky | Sep 2014 | B2 |
| 8827948 | Romo et al. | Sep 2014 | B2 |
| 8858424 | Hasegawa et al. | Oct 2014 | B2 |
| 8894610 | Macnamara et al. | Nov 2014 | B2 |
| 8929631 | Pfister et al. | Jan 2015 | B2 |
| 8945095 | Blumenkranz et al. | Feb 2015 | B2 |
| 9014851 | Wong et al. | Apr 2015 | B2 |
| 9023060 | Cooper et al. | May 2015 | B2 |
| 9084623 | Gomez et al. | Jul 2015 | B2 |
| 9125639 | Mathis et al. | Sep 2015 | B2 |
| 9129417 | Zheng et al. | Sep 2015 | B2 |
| 9138129 | Diolaiti | Sep 2015 | B2 |
| 9173713 | Hart et al. | Nov 2015 | B2 |
| 9183354 | Baker et al. | Nov 2015 | B2 |
| 9186046 | Ramamurthy et al. | Nov 2015 | B2 |
| 9199372 | Henderson et al. | Dec 2015 | B2 |
| 9226796 | Bowling et al. | Jan 2016 | B2 |
| 9256940 | Carelsen et al. | Feb 2016 | B2 |
| 9259274 | Prisco | Feb 2016 | B2 |
| 9272416 | Hourtash et al. | Mar 2016 | B2 |
| 9289578 | Walker et al. | Mar 2016 | B2 |
| 9302702 | Schepmann et al. | Apr 2016 | B1 |
| 9314306 | Yu | Apr 2016 | B2 |
| 9345456 | Tsonton et al. | May 2016 | B2 |
| 9358682 | Morales | Jun 2016 | B2 |
| 9452276 | Duindam et al. | Sep 2016 | B2 |
| 9459087 | Dunbar et al. | Oct 2016 | B2 |
| 9504604 | Alvarez | Nov 2016 | B2 |
| 9522034 | Johnson et al. | Dec 2016 | B2 |
| 9561083 | Yu et al. | Feb 2017 | B2 |
| 9603668 | Weingarten et al. | Mar 2017 | B2 |
| 9622827 | Yu et al. | Apr 2017 | B2 |
| 9629595 | Walker et al. | Apr 2017 | B2 |
| 9629682 | Wallace et al. | Apr 2017 | B2 |
| 9636184 | Lee et al. | May 2017 | B2 |
| 9668768 | Piron et al. | Jun 2017 | B2 |
| 9675422 | Hourtash et al. | Jun 2017 | B2 |
| 9710921 | Wong et al. | Jul 2017 | B2 |
| 9713509 | Schuh et al. | Jul 2017 | B2 |
| 9717563 | Tognaccini et al. | Aug 2017 | B2 |
| 9726476 | Ramamurthy et al. | Aug 2017 | B2 |
| 9727963 | Mintz et al. | Aug 2017 | B2 |
| 9737371 | Romo et al. | Aug 2017 | B2 |
| 9737373 | Schuh | Aug 2017 | B2 |
| 9744335 | Jiang | Aug 2017 | B2 |
| 9763741 | Alvarez et al. | Sep 2017 | B2 |
| 9782229 | Crawford et al. | Oct 2017 | B2 |
| 9788910 | Schuh | Oct 2017 | B2 |
| 9789608 | Itkowitz et al. | Oct 2017 | B2 |
| 9839481 | Blumenkranz et al. | Dec 2017 | B2 |
| 9844353 | Walker et al. | Dec 2017 | B2 |
| 9844412 | Bogusky et al. | Dec 2017 | B2 |
| 9867635 | Alvarez et al. | Jan 2018 | B2 |
| 9918681 | Wallace et al. | Mar 2018 | B2 |
| 9931025 | Graetzel et al. | Apr 2018 | B1 |
| 9949749 | Noonan et al. | Apr 2018 | B2 |
| 9955986 | Shah | May 2018 | B2 |
| 9962228 | Schuh et al. | May 2018 | B2 |
| 9980785 | Schuh | May 2018 | B2 |
| 9993313 | Schuh et al. | Jun 2018 | B2 |
| 10016900 | Meyer et al. | Jul 2018 | B1 |
| 10022192 | Ummalaneni | Jul 2018 | B1 |
| 10046140 | Kokish et al. | Aug 2018 | B2 |
| 10080576 | Romo et al. | Sep 2018 | B2 |
| 10123755 | Walker et al. | Nov 2018 | B2 |
| 10130345 | Wong et al. | Nov 2018 | B2 |
| 10136950 | Schoenefeld | Nov 2018 | B2 |
| 10136959 | Mintz et al. | Nov 2018 | B2 |
| 10143360 | Roelle et al. | Dec 2018 | B2 |
| 10143526 | Walker et al. | Dec 2018 | B2 |
| 10145747 | Lin et al. | Dec 2018 | B1 |
| 10149720 | Romo | Dec 2018 | B2 |
| 10159532 | Ummalaneni | Dec 2018 | B1 |
| 10159533 | Moll et al. | Dec 2018 | B2 |
| 10169875 | Mintz et al. | Jan 2019 | B2 |
| 10213264 | Tanner et al. | Feb 2019 | B2 |
| 10219874 | Yu et al. | Mar 2019 | B2 |
| 10231793 | Romo | Mar 2019 | B2 |
| 10231867 | Alvarez et al. | Mar 2019 | B2 |
| 10244926 | Noonan et al. | Apr 2019 | B2 |
| 10278778 | State et al. | May 2019 | B2 |
| 10285574 | Landey et al. | May 2019 | B2 |
| 10299870 | Connolly et al. | May 2019 | B2 |
| 10314463 | Agrawal et al. | Jun 2019 | B2 |
| 10383765 | Alvarez et al. | Aug 2019 | B2 |
| 10398518 | Yu et al. | Sep 2019 | B2 |
| 10405939 | Romo | Sep 2019 | B2 |
| 10405940 | Romo | Sep 2019 | B2 |
| 10426559 | Graetzel et al. | Oct 2019 | B2 |
| 10426661 | Kintz | Oct 2019 | B2 |
| 10434660 | Meyer et al. | Oct 2019 | B2 |
| 10454347 | Covington et al. | Oct 2019 | B2 |
| 10464209 | Ho et al. | Nov 2019 | B2 |
| 10470830 | Hill et al. | Nov 2019 | B2 |
| 10482599 | Mintz et al. | Nov 2019 | B2 |
| 10492741 | Walker et al. | Dec 2019 | B2 |
| 10493241 | Jiang | Dec 2019 | B2 |
| 10500001 | Yu et al. | Dec 2019 | B2 |
| 10517692 | Eyre et al. | Dec 2019 | B2 |
| 10524866 | Srinivasan et al. | Jan 2020 | B2 |
| 10531864 | Wong et al. | Jan 2020 | B2 |
| 10539478 | Lin et al. | Jan 2020 | B2 |
| 10543048 | Noonan | Jan 2020 | B2 |
| 10555778 | Ummalaneni | Feb 2020 | B2 |
| 10583271 | Bogusky | Mar 2020 | B2 |
| 10631949 | Schuh et al. | Apr 2020 | B2 |
| 10639109 | Bovay et al. | May 2020 | B2 |
| 10646291 | Turner | May 2020 | B2 |
| 20010000040 | Adams et al. | Mar 2001 | A1 |
| 20010021843 | Bosselmann et al. | Sep 2001 | A1 |
| 20010039421 | Heilbrun et al. | Nov 2001 | A1 |
| 20020035330 | Cline et al. | Mar 2002 | A1 |
| 20020065455 | Ben-Haim et al. | May 2002 | A1 |
| 20020077533 | Bieger et al. | Jun 2002 | A1 |
| 20020082612 | Moll et al. | Jun 2002 | A1 |
| 20020120188 | Brock et al. | Aug 2002 | A1 |
| 20020128535 | Kikuchi et al. | Sep 2002 | A1 |
| 20020161280 | Chatenever et al. | Oct 2002 | A1 |
| 20020173878 | Watanabe et al. | Nov 2002 | A1 |
| 20030045778 | Ohline et al. | Mar 2003 | A1 |
| 20030105603 | Hardesty | Jun 2003 | A1 |
| 20030125622 | Schweikard et al. | Jul 2003 | A1 |
| 20030181809 | Hall et al. | Sep 2003 | A1 |
| 20030182091 | Kukuk | Sep 2003 | A1 |
| 20030195664 | Nowlin et al. | Oct 2003 | A1 |
| 20030199765 | Stetten | Oct 2003 | A1 |
| 20040047044 | Dalton | Mar 2004 | A1 |
| 20040072066 | Cho et al. | Apr 2004 | A1 |
| 20040176751 | Weitzner et al. | Sep 2004 | A1 |
| 20040186349 | Ewers et al. | Sep 2004 | A1 |
| 20040249267 | Gilboa | Dec 2004 | A1 |
| 20040257021 | Chang et al. | Dec 2004 | A1 |
| 20040263535 | Birkenbach et al. | Dec 2004 | A1 |
| 20050027397 | Niemeyer | Feb 2005 | A1 |
| 20050043718 | Madhani et al. | Feb 2005 | A1 |
| 20050060006 | Pflueger et al. | Mar 2005 | A1 |
| 20050065400 | Banik et al. | Mar 2005 | A1 |
| 20050080333 | Piron | Apr 2005 | A1 |
| 20050085714 | Foley et al. | Apr 2005 | A1 |
| 20050107679 | Geiger et al. | May 2005 | A1 |
| 20050107917 | Smith et al. | May 2005 | A1 |
| 20050143649 | Minai et al. | Jun 2005 | A1 |
| 20050143655 | Satoh | Jun 2005 | A1 |
| 20050182295 | Soper et al. | Aug 2005 | A1 |
| 20050193451 | Quistgaard et al. | Sep 2005 | A1 |
| 20050222554 | Wallace et al. | Oct 2005 | A1 |
| 20050234293 | Yamamoto et al. | Oct 2005 | A1 |
| 20050256398 | Hastings et al. | Nov 2005 | A1 |
| 20050261551 | Couvillon | Nov 2005 | A1 |
| 20050272975 | McWeeney et al. | Dec 2005 | A1 |
| 20060004286 | Chang et al. | Jan 2006 | A1 |
| 20060015096 | Hauck et al. | Jan 2006 | A1 |
| 20060025668 | Peterson et al. | Feb 2006 | A1 |
| 20060041293 | Mehdizadeh et al. | Feb 2006 | A1 |
| 20060058617 | Sano et al. | Mar 2006 | A1 |
| 20060058643 | Florent et al. | Mar 2006 | A1 |
| 20060079745 | Viswanathan | Apr 2006 | A1 |
| 20060084860 | Geiger et al. | Apr 2006 | A1 |
| 20060095066 | Chang et al. | May 2006 | A1 |
| 20060098851 | Shoham et al. | May 2006 | A1 |
| 20060149134 | Soper et al. | Jul 2006 | A1 |
| 20060173290 | Lavallee et al. | Aug 2006 | A1 |
| 20060178556 | Hasser et al. | Aug 2006 | A1 |
| 20060184016 | Glossop | Aug 2006 | A1 |
| 20060200026 | Wallace et al. | Sep 2006 | A1 |
| 20060200049 | Leo et al. | Sep 2006 | A1 |
| 20060209019 | Hu | Sep 2006 | A1 |
| 20060258935 | Pile-Spellman et al. | Nov 2006 | A1 |
| 20060258938 | Hoffman et al. | Nov 2006 | A1 |
| 20070013336 | Nowlin et al. | Jan 2007 | A1 |
| 20070032826 | Schwartz | Feb 2007 | A1 |
| 20070043455 | Viswanathan et al. | Feb 2007 | A1 |
| 20070055128 | Glossop | Mar 2007 | A1 |
| 20070055144 | Neustadter et al. | Mar 2007 | A1 |
| 20070073136 | Metzger | Mar 2007 | A1 |
| 20070083193 | Werneth et al. | Apr 2007 | A1 |
| 20070123748 | Meglan | May 2007 | A1 |
| 20070135886 | Maschke | Jun 2007 | A1 |
| 20070142971 | Schena | Jun 2007 | A1 |
| 20070150155 | Kawai et al. | Jun 2007 | A1 |
| 20070156019 | Larkin et al. | Jul 2007 | A1 |
| 20070161857 | Durant et al. | Jul 2007 | A1 |
| 20070167743 | Honda et al. | Jul 2007 | A1 |
| 20070167801 | Webler et al. | Jul 2007 | A1 |
| 20070208252 | Makower | Sep 2007 | A1 |
| 20070232856 | Ueno et al. | Oct 2007 | A1 |
| 20070249911 | Simon | Oct 2007 | A1 |
| 20070253599 | White et al. | Nov 2007 | A1 |
| 20070269001 | Maschke | Nov 2007 | A1 |
| 20070287992 | Diolaiti et al. | Dec 2007 | A1 |
| 20070293721 | Gilboa | Dec 2007 | A1 |
| 20070299353 | Harlev et al. | Dec 2007 | A1 |
| 20080027313 | Shachar | Jan 2008 | A1 |
| 20080046122 | Manzo et al. | Feb 2008 | A1 |
| 20080071140 | Gattani et al. | Mar 2008 | A1 |
| 20080079421 | Jensen | Apr 2008 | A1 |
| 20080081982 | Simon | Apr 2008 | A1 |
| 20080103389 | Begelman et al. | May 2008 | A1 |
| 20080108870 | Wiita et al. | May 2008 | A1 |
| 20080118118 | Berger | May 2008 | A1 |
| 20080118135 | Averbuch et al. | May 2008 | A1 |
| 20080123921 | Gielen et al. | May 2008 | A1 |
| 20080140087 | Barbagli | Jun 2008 | A1 |
| 20080147089 | Loh et al. | Jun 2008 | A1 |
| 20080159653 | Dunki-Jacobs et al. | Jul 2008 | A1 |
| 20080161681 | Hauck | Jul 2008 | A1 |
| 20080183064 | Chandonnet et al. | Jul 2008 | A1 |
| 20080183068 | Carls et al. | Jul 2008 | A1 |
| 20080183073 | Higgins et al. | Jul 2008 | A1 |
| 20080183188 | Carls et al. | Jul 2008 | A1 |
| 20080201016 | Finlay | Aug 2008 | A1 |
| 20080207997 | Higgins et al. | Aug 2008 | A1 |
| 20080212082 | Froggatt et al. | Sep 2008 | A1 |
| 20080218588 | Stetten | Sep 2008 | A1 |
| 20080218743 | Stetten | Sep 2008 | A1 |
| 20080218770 | Moll et al. | Sep 2008 | A1 |
| 20080231221 | Ogawa | Sep 2008 | A1 |
| 20080243142 | Gildenberg | Oct 2008 | A1 |
| 20080249640 | Vittor et al. | Oct 2008 | A1 |
| 20080255505 | Carlson et al. | Oct 2008 | A1 |
| 20080262297 | Gilboa et al. | Oct 2008 | A1 |
| 20080275349 | Halperin et al. | Nov 2008 | A1 |
| 20080287963 | Rogers et al. | Nov 2008 | A1 |
| 20080306490 | Lakin et al. | Dec 2008 | A1 |
| 20080312501 | Hasegawa et al. | Dec 2008 | A1 |
| 20080312771 | Sugiura | Dec 2008 | A1 |
| 20090005768 | Sharareh et al. | Jan 2009 | A1 |
| 20090030307 | Govari et al. | Jan 2009 | A1 |
| 20090048611 | Funda et al. | Feb 2009 | A1 |
| 20090054729 | Mori et al. | Feb 2009 | A1 |
| 20090062611 | Toyama | Mar 2009 | A1 |
| 20090062813 | Prisco et al. | Mar 2009 | A1 |
| 20090076476 | Barbagli et al. | Mar 2009 | A1 |
| 20090076534 | Shelton, IV et al. | Mar 2009 | A1 |
| 20090149867 | Glozman et al. | Jun 2009 | A1 |
| 20090184825 | Anderson | Jul 2009 | A1 |
| 20090198298 | Kaiser et al. | Aug 2009 | A1 |
| 20090227861 | Ganatra et al. | Sep 2009 | A1 |
| 20090228020 | Wallace et al. | Sep 2009 | A1 |
| 20090245600 | Hoffman et al. | Oct 2009 | A1 |
| 20090248036 | Hoffman et al. | Oct 2009 | A1 |
| 20090256905 | Tashiro | Oct 2009 | A1 |
| 20090259099 | Zhou et al. | Oct 2009 | A1 |
| 20090259230 | Khadem et al. | Oct 2009 | A1 |
| 20090262109 | Markowitz et al. | Oct 2009 | A1 |
| 20090287354 | Choi | Nov 2009 | A1 |
| 20090292166 | Ito et al. | Nov 2009 | A1 |
| 20090295797 | Sakaguchi | Dec 2009 | A1 |
| 20090324161 | Prisco | Dec 2009 | A1 |
| 20090326318 | Tognaccini et al. | Dec 2009 | A1 |
| 20100008555 | Trumer et al. | Jan 2010 | A1 |
| 20100030061 | Canfield et al. | Feb 2010 | A1 |
| 20100030115 | Fujimoto et al. | Feb 2010 | A1 |
| 20100039506 | Sarvestani et al. | Feb 2010 | A1 |
| 20100041949 | Tolkowsky | Feb 2010 | A1 |
| 20100054536 | Huang et al. | Mar 2010 | A1 |
| 20100069920 | Naylor et al. | Mar 2010 | A1 |
| 20100076263 | Tanaka et al. | Mar 2010 | A1 |
| 20100082041 | Prisco | Apr 2010 | A1 |
| 20100121138 | Goldenberg et al. | May 2010 | A1 |
| 20100121139 | OuYang et al. | May 2010 | A1 |
| 20100160733 | Gilboa | Jun 2010 | A1 |
| 20100161022 | Tolkowsky | Jun 2010 | A1 |
| 20100161129 | Costa et al. | Jun 2010 | A1 |
| 20100168918 | Zhao et al. | Jul 2010 | A1 |
| 20100198170 | Umeda et al. | Aug 2010 | A1 |
| 20100204713 | Morales | Aug 2010 | A1 |
| 20100225209 | Goldberg et al. | Sep 2010 | A1 |
| 20100228266 | Hourtash | Sep 2010 | A1 |
| 20100234856 | Stoianovici et al. | Sep 2010 | A1 |
| 20100234857 | Itkowitz et al. | Sep 2010 | A1 |
| 20100240989 | Stoianovici et al. | Sep 2010 | A1 |
| 20100256812 | Tsusaka et al. | Oct 2010 | A1 |
| 20100290530 | Huang et al. | Nov 2010 | A1 |
| 20100292565 | Meyer et al. | Nov 2010 | A1 |
| 20100298641 | Tanaka | Nov 2010 | A1 |
| 20100328455 | Nam et al. | Dec 2010 | A1 |
| 20110009880 | Prisco et al. | Jan 2011 | A1 |
| 20110015484 | Alvarez et al. | Jan 2011 | A1 |
| 20110021926 | Spencer et al. | Jan 2011 | A1 |
| 20110054303 | Barrick et al. | Mar 2011 | A1 |
| 20110082366 | Scully et al. | Apr 2011 | A1 |
| 20110082462 | Suarez et al. | Apr 2011 | A1 |
| 20110092808 | Shachar et al. | Apr 2011 | A1 |
| 20110137122 | Kawai | Jun 2011 | A1 |
| 20110153252 | Govari et al. | Jun 2011 | A1 |
| 20110160570 | Kariv et al. | Jun 2011 | A1 |
| 20110184238 | Higgins et al. | Jul 2011 | A1 |
| 20110196199 | Donhowe et al. | Aug 2011 | A1 |
| 20110218676 | Okazaki | Sep 2011 | A1 |
| 20110234780 | Ito et al. | Sep 2011 | A1 |
| 20110238082 | Wenderow et al. | Sep 2011 | A1 |
| 20110245665 | Nentwick | Oct 2011 | A1 |
| 20110248987 | Mitchell | Oct 2011 | A1 |
| 20110249016 | Zhang et al. | Oct 2011 | A1 |
| 20110257480 | Takahashi et al. | Oct 2011 | A1 |
| 20110258842 | Dukesherer et al. | Oct 2011 | A1 |
| 20110276179 | Banks et al. | Nov 2011 | A1 |
| 20110277775 | Holop et al. | Nov 2011 | A1 |
| 20110319910 | Roelle et al. | Dec 2011 | A1 |
| 20120000427 | Nilsson | Jan 2012 | A1 |
| 20120046521 | Hunter et al. | Feb 2012 | A1 |
| 20120046522 | Naito | Feb 2012 | A1 |
| 20120056986 | Popovic | Mar 2012 | A1 |
| 20120059249 | Verard et al. | Mar 2012 | A1 |
| 20120062714 | Liu et al. | Mar 2012 | A1 |
| 20120065481 | Hunter et al. | Mar 2012 | A1 |
| 20120069167 | Liu et al. | Mar 2012 | A1 |
| 20120071752 | Sewell et al. | Mar 2012 | A1 |
| 20120071782 | Patil et al. | Mar 2012 | A1 |
| 20120071822 | Romo et al. | Mar 2012 | A1 |
| 20120071894 | Tanner et al. | Mar 2012 | A1 |
| 20120082351 | Higgins et al. | Apr 2012 | A1 |
| 20120120305 | Takahashi | May 2012 | A1 |
| 20120123441 | Au et al. | May 2012 | A1 |
| 20120130217 | Kauphusman et al. | May 2012 | A1 |
| 20120165656 | Montag et al. | Jun 2012 | A1 |
| 20120191079 | Moll et al. | Jul 2012 | A1 |
| 20120209069 | Popovic et al. | Aug 2012 | A1 |
| 20120209293 | Carlson et al. | Aug 2012 | A1 |
| 20120215094 | Rahimian et al. | Aug 2012 | A1 |
| 20120219185 | Hu et al. | Aug 2012 | A1 |
| 20120221007 | Batten et al. | Aug 2012 | A1 |
| 20120239060 | Orban, III | Sep 2012 | A1 |
| 20120253276 | Govari et al. | Oct 2012 | A1 |
| 20120283745 | Goldberg et al. | Nov 2012 | A1 |
| 20120283747 | Popovic | Nov 2012 | A1 |
| 20120289777 | Chopra et al. | Nov 2012 | A1 |
| 20120289783 | Duindam et al. | Nov 2012 | A1 |
| 20120302869 | Koyrakh et al. | Nov 2012 | A1 |
| 20120328077 | Bouvier | Dec 2012 | A1 |
| 20130018306 | Ludwin | Jan 2013 | A1 |
| 20130060146 | Yang et al. | Mar 2013 | A1 |
| 20130085330 | Ramamurthy et al. | Apr 2013 | A1 |
| 20130090530 | Ramamurthy et al. | Apr 2013 | A1 |
| 20130102846 | Sjostrom et al. | Apr 2013 | A1 |
| 20130123580 | Peters et al. | May 2013 | A1 |
| 20130131503 | Schneider et al. | May 2013 | A1 |
| 20130144116 | Cooper et al. | Jun 2013 | A1 |
| 20130165854 | Sandhu et al. | Jun 2013 | A1 |
| 20130165945 | Roelle et al. | Jun 2013 | A9 |
| 20130204124 | Duindam et al. | Aug 2013 | A1 |
| 20130209208 | Bailey et al. | Aug 2013 | A1 |
| 20130218005 | Desai et al. | Aug 2013 | A1 |
| 20130225942 | Holsing et al. | Aug 2013 | A1 |
| 20130243153 | Sra et al. | Sep 2013 | A1 |
| 20130246334 | Ahuja et al. | Sep 2013 | A1 |
| 20130259315 | Angot et al. | Oct 2013 | A1 |
| 20130274783 | Wynberg | Oct 2013 | A1 |
| 20130303891 | Chopra | Nov 2013 | A1 |
| 20130303892 | Zhao et al. | Nov 2013 | A1 |
| 20130325030 | Hourtash et al. | Dec 2013 | A1 |
| 20130345718 | Crawford et al. | Dec 2013 | A1 |
| 20140001235 | Shelton, IV | Jan 2014 | A1 |
| 20140051049 | Jarc et al. | Feb 2014 | A1 |
| 20140058406 | Tsekos | Feb 2014 | A1 |
| 20140107390 | Brown et al. | Apr 2014 | A1 |
| 20140114180 | Jain | Apr 2014 | A1 |
| 20140135985 | Coste-Maniere et al. | May 2014 | A1 |
| 20140142591 | Alvarez et al. | May 2014 | A1 |
| 20140148808 | Inkpen et al. | May 2014 | A1 |
| 20140163664 | Goldsmith | Jun 2014 | A1 |
| 20140180063 | Zhao et al. | Jun 2014 | A1 |
| 20140222207 | Bowling et al. | Aug 2014 | A1 |
| 20140235943 | Paris et al. | Aug 2014 | A1 |
| 20140243801 | Fanelli et al. | Aug 2014 | A1 |
| 20140243849 | Saglam et al. | Aug 2014 | A1 |
| 20140257333 | Blumenkranz | Sep 2014 | A1 |
| 20140257746 | Dunbar et al. | Sep 2014 | A1 |
| 20140264081 | Walker et al. | Sep 2014 | A1 |
| 20140275988 | Walker et al. | Sep 2014 | A1 |
| 20140276033 | Brannan et al. | Sep 2014 | A1 |
| 20140276937 | Wong et al. | Sep 2014 | A1 |
| 20140277333 | Lewis et al. | Sep 2014 | A1 |
| 20140296655 | Akhbardeh et al. | Oct 2014 | A1 |
| 20140296657 | Izmirli et al. | Oct 2014 | A1 |
| 20140296870 | Stern et al. | Oct 2014 | A1 |
| 20140309527 | Namati et al. | Oct 2014 | A1 |
| 20140309625 | Okamoto et al. | Oct 2014 | A1 |
| 20140316420 | Ballard et al. | Oct 2014 | A1 |
| 20140343416 | Panescu et al. | Nov 2014 | A1 |
| 20140343569 | Turner | Nov 2014 | A1 |
| 20140350391 | Prisco et al. | Nov 2014 | A1 |
| 20140357984 | Wallace et al. | Dec 2014 | A1 |
| 20140364739 | Liu et al. | Dec 2014 | A1 |
| 20140364870 | Alvarez et al. | Dec 2014 | A1 |
| 20150025549 | Kilroy et al. | Jan 2015 | A1 |
| 20150045675 | Chernomorsky | Feb 2015 | A1 |
| 20150051482 | Liu et al. | Feb 2015 | A1 |
| 20150054929 | Ito et al. | Feb 2015 | A1 |
| 20150057498 | Akimoto et al. | Feb 2015 | A1 |
| 20150073266 | Brannan et al. | Mar 2015 | A1 |
| 20150073267 | Brannan et al. | Mar 2015 | A1 |
| 20150088161 | Hata et al. | Mar 2015 | A1 |
| 20150104284 | Riedel | Apr 2015 | A1 |
| 20150119628 | Bharat et al. | Apr 2015 | A1 |
| 20150119645 | Baldwin | Apr 2015 | A1 |
| 20150141808 | Elhawary et al. | May 2015 | A1 |
| 20150141858 | Razavi et al. | May 2015 | A1 |
| 20150142013 | Tanner et al. | May 2015 | A1 |
| 20150150635 | Kilroy et al. | Jun 2015 | A1 |
| 20150150636 | Hagn et al. | Jun 2015 | A1 |
| 20150202015 | Elhawary et al. | Jul 2015 | A1 |
| 20150223725 | Engel et al. | Aug 2015 | A1 |
| 20150223832 | Swaney et al. | Aug 2015 | A1 |
| 20150223897 | Kostrzewski et al. | Aug 2015 | A1 |
| 20150223902 | Walker et al. | Aug 2015 | A1 |
| 20150255782 | Kim et al. | Sep 2015 | A1 |
| 20150265087 | Messick, Jr. | Sep 2015 | A1 |
| 20150265359 | Camarillo | Sep 2015 | A1 |
| 20150265368 | Chopra et al. | Sep 2015 | A1 |
| 20150265807 | Park et al. | Sep 2015 | A1 |
| 20150275986 | Cooper | Oct 2015 | A1 |
| 20150287192 | Sasaki | Oct 2015 | A1 |
| 20150297133 | Jouanique-Dubuis et al. | Oct 2015 | A1 |
| 20150297299 | Yeung et al. | Oct 2015 | A1 |
| 20150311838 | Moule et al. | Oct 2015 | A1 |
| 20150313503 | Seibel et al. | Nov 2015 | A1 |
| 20150342695 | He et al. | Dec 2015 | A1 |
| 20150359597 | Gombert et al. | Dec 2015 | A1 |
| 20160000302 | Brown et al. | Jan 2016 | A1 |
| 20160000414 | Brown et al. | Jan 2016 | A1 |
| 20160000495 | Elliott et al. | Jan 2016 | A1 |
| 20160000520 | Lachmanovich et al. | Jan 2016 | A1 |
| 20160001038 | Romo et al. | Jan 2016 | A1 |
| 20160005168 | Merlet | Jan 2016 | A1 |
| 20160005220 | Weingarten et al. | Jan 2016 | A1 |
| 20160005576 | Tsukamoto | Jan 2016 | A1 |
| 20160008033 | Hawkins et al. | Jan 2016 | A1 |
| 20160016319 | Remirez et al. | Jan 2016 | A1 |
| 20160045269 | Elhawary et al. | Feb 2016 | A1 |
| 20160051221 | Dickhans et al. | Feb 2016 | A1 |
| 20160066794 | Klinder et al. | Mar 2016 | A1 |
| 20160073928 | Soper et al. | Mar 2016 | A1 |
| 20160075030 | Takahashi | Mar 2016 | A1 |
| 20160081568 | Kolberg et al. | Mar 2016 | A1 |
| 20160100772 | Ikuma et al. | Apr 2016 | A1 |
| 20160111192 | Suzara | Apr 2016 | A1 |
| 20160128992 | Hudson et al. | May 2016 | A1 |
| 20160166320 | Ciulla et al. | Jun 2016 | A1 |
| 20160183841 | Duindam et al. | Jun 2016 | A1 |
| 20160199134 | Brown et al. | Jul 2016 | A1 |
| 20160206389 | Miller | Jul 2016 | A1 |
| 20160213432 | Flexman et al. | Jul 2016 | A1 |
| 20160228032 | Walker et al. | Aug 2016 | A1 |
| 20160270865 | Landey et al. | Sep 2016 | A1 |
| 20160278865 | Capote et al. | Sep 2016 | A1 |
| 20160287053 | Miura | Oct 2016 | A1 |
| 20160287111 | Jacobsen | Oct 2016 | A1 |
| 20160287279 | Bovay et al. | Oct 2016 | A1 |
| 20160287346 | Hyodo et al. | Oct 2016 | A1 |
| 20160314710 | Jarc et al. | Oct 2016 | A1 |
| 20160331469 | Hall et al. | Nov 2016 | A1 |
| 20160338787 | Popovic et al. | Nov 2016 | A1 |
| 20160346038 | Helgeson et al. | Dec 2016 | A1 |
| 20160346924 | Hasegawa et al. | Dec 2016 | A1 |
| 20160354057 | Hansen et al. | Dec 2016 | A1 |
| 20160360947 | Iida et al. | Dec 2016 | A1 |
| 20160360949 | Hyodo et al. | Dec 2016 | A1 |
| 20160372743 | Cho et al. | Dec 2016 | A1 |
| 20170007337 | Dan | Jan 2017 | A1 |
| 20170023423 | Jackson et al. | Jan 2017 | A1 |
| 20170055851 | Al-Ali | Mar 2017 | A1 |
| 20170056215 | Nagesh et al. | Mar 2017 | A1 |
| 20170068796 | Passerini et al. | Mar 2017 | A1 |
| 20170071456 | Ratnakar | Mar 2017 | A1 |
| 20170079725 | Hoffman et al. | Mar 2017 | A1 |
| 20170079726 | Hoffman et al. | Mar 2017 | A1 |
| 20170095299 | Hendrick et al. | Apr 2017 | A1 |
| 20170100197 | Zubiate et al. | Apr 2017 | A1 |
| 20170106904 | Hanson et al. | Apr 2017 | A1 |
| 20170119412 | Noonan et al. | May 2017 | A1 |
| 20170135710 | Hasegawa et al. | May 2017 | A1 |
| 20170135718 | Lyons | May 2017 | A1 |
| 20170135833 | Syed | May 2017 | A1 |
| 20170143442 | Tesar et al. | May 2017 | A1 |
| 20170165503 | Hautvast et al. | Jun 2017 | A1 |
| 20170181809 | Panescu et al. | Jun 2017 | A1 |
| 20170189118 | Chopra et al. | Jul 2017 | A1 |
| 20170189131 | Weir | Jul 2017 | A1 |
| 20170202627 | Sramek et al. | Jul 2017 | A1 |
| 20170209073 | Sramek et al. | Jul 2017 | A1 |
| 20170209162 | Sperry et al. | Jul 2017 | A1 |
| 20170215808 | Shimol et al. | Aug 2017 | A1 |
| 20170215969 | Zhai et al. | Aug 2017 | A1 |
| 20170231647 | Saunders et al. | Aug 2017 | A1 |
| 20170238807 | Vertikov | Aug 2017 | A9 |
| 20170245854 | Zemlok et al. | Aug 2017 | A1 |
| 20170245885 | Lenker | Aug 2017 | A1 |
| 20170251988 | Weber et al. | Sep 2017 | A1 |
| 20170258366 | Tupin, Jr. et al. | Sep 2017 | A1 |
| 20170280978 | Yamamoto et al. | Oct 2017 | A1 |
| 20170281049 | Yamamoto et al. | Oct 2017 | A1 |
| 20170290631 | Lee et al. | Oct 2017 | A1 |
| 20170296032 | Li | Oct 2017 | A1 |
| 20170296202 | Brown | Oct 2017 | A1 |
| 20170303889 | Grim et al. | Oct 2017 | A1 |
| 20170303941 | Eisner | Oct 2017 | A1 |
| 20170304015 | Tavallaei et al. | Oct 2017 | A1 |
| 20170325715 | Mehendale et al. | Nov 2017 | A1 |
| 20170325896 | Donhowe et al. | Nov 2017 | A1 |
| 20170326337 | Romoscanu et al. | Nov 2017 | A1 |
| 20170340241 | Yamada | Nov 2017 | A1 |
| 20170340396 | Romo et al. | Nov 2017 | A1 |
| 20170348067 | Krimsky | Dec 2017 | A1 |
| 20170360508 | Germain et al. | Dec 2017 | A1 |
| 20180025666 | Ho et al. | Jan 2018 | A1 |
| 20180036033 | Ignagni | Feb 2018 | A1 |
| 20180055576 | Koyrakh et al. | Mar 2018 | A1 |
| 20180055582 | Krimsky | Mar 2018 | A1 |
| 20180064498 | Kapadia et al. | Mar 2018 | A1 |
| 20180098690 | Iwaki | Apr 2018 | A1 |
| 20180098817 | Nichogi | Apr 2018 | A1 |
| 20180169671 | Winter et al. | Jun 2018 | A1 |
| 20180214011 | Graetzel et al. | Aug 2018 | A1 |
| 20180217734 | Koenig et al. | Aug 2018 | A1 |
| 20180221038 | Noonan et al. | Aug 2018 | A1 |
| 20180221039 | Shah | Aug 2018 | A1 |
| 20180240237 | Donhowe et al. | Aug 2018 | A1 |
| 20180250083 | Schuh et al. | Sep 2018 | A1 |
| 20180279852 | Rafii-Tari et al. | Oct 2018 | A1 |
| 20180280660 | Landey et al. | Oct 2018 | A1 |
| 20180286108 | Hirakawa | Oct 2018 | A1 |
| 20180289394 | Shah | Oct 2018 | A1 |
| 20180289431 | Draper et al. | Oct 2018 | A1 |
| 20180308247 | Gupta | Oct 2018 | A1 |
| 20180325499 | Landey et al. | Nov 2018 | A1 |
| 20180333044 | Jenkins | Nov 2018 | A1 |
| 20180338799 | Hladio et al. | Nov 2018 | A1 |
| 20180360435 | Romo | Dec 2018 | A1 |
| 20180368920 | Ummalaneni | Dec 2018 | A1 |
| 20190000559 | Berman et al. | Jan 2019 | A1 |
| 20190000560 | Berman et al. | Jan 2019 | A1 |
| 20190000568 | Connolly | Jan 2019 | A1 |
| 20190000576 | Mintz et al. | Jan 2019 | A1 |
| 20190046814 | Senden et al. | Feb 2019 | A1 |
| 20190066314 | Abhari et al. | Feb 2019 | A1 |
| 20190083183 | Moll et al. | Mar 2019 | A1 |
| 20190086349 | Nelson et al. | Mar 2019 | A1 |
| 20190110839 | Rafii-Tari et al. | Apr 2019 | A1 |
| 20190125164 | Roelle et al. | May 2019 | A1 |
| 20190139216 | Georgescu | May 2019 | A1 |
| 20190151148 | Alvarez et al. | May 2019 | A1 |
| 20190167366 | Ummalaneni et al. | Jun 2019 | A1 |
| 20190167367 | Walker et al. | Jun 2019 | A1 |
| 20190175009 | Mintz et al. | Jun 2019 | A1 |
| 20190175062 | Rafii-Tari et al. | Jun 2019 | A1 |
| 20190175799 | Hsu et al. | Jun 2019 | A1 |
| 20190183585 | Rafii-Tari et al. | Jun 2019 | A1 |
| 20190183587 | Rafii-Tari et al. | Jun 2019 | A1 |
| 20190209252 | Walker et al. | Jul 2019 | A1 |
| 20190216548 | Ummalaneni | Jul 2019 | A1 |
| 20190216576 | Eyre et al. | Jul 2019 | A1 |
| 20190223974 | Romo et al. | Jul 2019 | A1 |
| 20190228525 | Mintz et al. | Jul 2019 | A1 |
| 20190246882 | Graetzel et al. | Aug 2019 | A1 |
| 20190262086 | Connolly et al. | Aug 2019 | A1 |
| 20190269468 | Hsu et al. | Sep 2019 | A1 |
| 20190274764 | Romo | Sep 2019 | A1 |
| 20190287673 | Michihata et al. | Sep 2019 | A1 |
| 20190290109 | Agrawal et al. | Sep 2019 | A1 |
| 20190298160 | Ummalaneni et al. | Oct 2019 | A1 |
| 20190298460 | Al-Jadda et al. | Oct 2019 | A1 |
| 20190298465 | Chin et al. | Oct 2019 | A1 |
| 20190328213 | Landey et al. | Oct 2019 | A1 |
| 20190336238 | Yu et al. | Nov 2019 | A1 |
| 20190365201 | Noonan et al. | Dec 2019 | A1 |
| 20190365209 | Ye et al. | Dec 2019 | A1 |
| 20190365479 | Rafii-Tari | Dec 2019 | A1 |
| 20190365486 | Srinivasan et al. | Dec 2019 | A1 |
| 20190374297 | Wallace et al. | Dec 2019 | A1 |
| 20190375383 | Auer | Dec 2019 | A1 |
| 20190380787 | Ye et al. | Dec 2019 | A1 |
| 20190380797 | Yu et al. | Dec 2019 | A1 |
| 20200000530 | DeFonzo et al. | Jan 2020 | A1 |
| 20200000533 | Schuh et al. | Jan 2020 | A1 |
| 20200008874 | Barbagli et al. | Jan 2020 | A1 |
| 20200022767 | Hill et al. | Jan 2020 | A1 |
| 20200038123 | Graetzel et al. | Feb 2020 | A1 |
| 20200039086 | Meyer et al. | Feb 2020 | A1 |
| 20200046434 | Graetzel et al. | Feb 2020 | A1 |
| 20200054405 | Schuh et al. | Feb 2020 | A1 |
| 20200054408 | Schuh et al. | Feb 2020 | A1 |
| 20200060516 | Baez, Jr. | Feb 2020 | A1 |
| 20200078103 | Duindam et al. | Mar 2020 | A1 |
| 20200085516 | DeFonzo et al. | Mar 2020 | A1 |
| 20200093549 | Chin et al. | Mar 2020 | A1 |
| 20200093554 | Schuh et al. | Mar 2020 | A1 |
| 20200100845 | Julian | Apr 2020 | A1 |
| 20200100853 | Ho et al. | Apr 2020 | A1 |
| 20200100855 | Leparmentier et al. | Apr 2020 | A1 |
| 20200101264 | Jiang | Apr 2020 | A1 |
| 20200107894 | Wallace et al. | Apr 2020 | A1 |
| 20200121502 | Kintz | Apr 2020 | A1 |
| 20200146769 | Eyre et al. | May 2020 | A1 |
| 20200155084 | Walker et al. | May 2020 | A1 |
| 20200170630 | Wong et al. | Jun 2020 | A1 |
| 20200170720 | Ummalaneni | Jun 2020 | A1 |
| 20200171660 | Ho et al. | Jun 2020 | A1 |
| 20200188043 | Yu et al. | Jun 2020 | A1 |
| 20200197112 | Chin et al. | Jun 2020 | A1 |
| 20200206472 | Ma et al. | Jul 2020 | A1 |
| 20200217733 | Lin et al. | Jul 2020 | A1 |
| 20200222134 | Schuh et al. | Jul 2020 | A1 |
| 20200237458 | DeFonzo et al. | Jul 2020 | A1 |
| 20200246591 | Bogusky | Aug 2020 | A1 |
| 20200261172 | Romo et al. | Aug 2020 | A1 |
| 20200268459 | Noonan | Aug 2020 | A1 |
| 20200268460 | Tse et al. | Aug 2020 | A1 |
| 20200281787 | Ruiz | Sep 2020 | A1 |
| 20200297437 | Schuh et al. | Sep 2020 | A1 |
| 20200305922 | Yan et al. | Oct 2020 | A1 |
| 20200305983 | Yampolsky et al. | Oct 2020 | A1 |
| 20200305989 | Schuh et al. | Oct 2020 | A1 |
| 20200315717 | Bovay et al. | Oct 2020 | A1 |
| 20200315723 | Hassan et al. | Oct 2020 | A1 |
| 20200323596 | Moll et al. | Oct 2020 | A1 |
| 20200330167 | Romo et al. | Oct 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 1364275 | Aug 2002 | CN |
| 1511249 | Jul 2004 | CN |
| 1846181 | Oct 2006 | CN |
| 1857877 | Nov 2006 | CN |
| 101147676 | Mar 2008 | CN |
| 102316817 | Jan 2012 | CN |
| 101325920 | Feb 2012 | CN |
| 102341057 | Feb 2012 | CN |
| 101222882 | Mar 2013 | CN |
| 102973317 | Mar 2013 | CN |
| 103705307 | Apr 2014 | CN |
| 103735313 | Apr 2014 | CN |
| 102458295 | Jun 2014 | CN |
| 103930063 | Jul 2014 | CN |
| 102711586 | Jun 2015 | CN |
| 103565529 | Jun 2015 | CN |
| 103767659 | Jun 2015 | CN |
| 105030331 | Nov 2015 | CN |
| 105511881 | Apr 2016 | CN |
| 105559886 | May 2016 | CN |
| 104758066 | May 2017 | CN |
| 105559850 | Aug 2017 | CN |
| 107028659 | Aug 2017 | CN |
| 103813748 | Apr 2018 | CN |
| 108348139 | Jul 2018 | CN |
| 104931059 | Sep 2018 | CN |
| 104684502 | Oct 2018 | CN |
| 106821498 | Feb 2020 | CN |
| 102013100605 | Jul 2014 | DE |
| 0347098 | Feb 1996 | EP |
| 1250986 | Oct 2002 | EP |
| 1800593 | Jan 2009 | EP |
| 2158834 | Mar 2010 | EP |
| 1566150 | Apr 2010 | EP |
| 2615992 | Jul 2013 | EP |
| 3025630 | Mar 2017 | EP |
| 2392435 | Dec 2020 | EP |
| 2008528130 | Jul 2008 | JP |
| 2009509654 | Mar 2009 | JP |
| 2009524530 | Jul 2009 | JP |
| 2011088260 | May 2011 | JP |
| 2013510662 | Mar 2013 | JP |
| 1020140009359 | Jan 2014 | KR |
| 2569699 | Nov 2015 | RU |
| 0156457 | Aug 2001 | WO |
| 2004029782 | Apr 2004 | WO |
| 2005078128 | Aug 2005 | WO |
| 2006122061 | Nov 2006 | WO |
| 2009097461 | Aug 2009 | WO |
| 2009120940 | Oct 2009 | WO |
| 2010127162 | Nov 2010 | WO |
| 2011002215 | Apr 2011 | WO |
| 2011132409 | Oct 2011 | WO |
| 2012044334 | Apr 2012 | WO |
| 2012082719 | Jun 2012 | WO |
| 2014114551 | Jul 2014 | WO |
| 2015089013 | Jun 2015 | WO |
| 2015142957 | Sep 2015 | WO |
| 2017036774 | Mar 2017 | WO |
| 2017053698 | Mar 2017 | WO |
| 2017066108 | Apr 2017 | WO |
| 2017048194 | Jul 2017 | WO |
| 2017146890 | Aug 2017 | WO |
| 2017167754 | Oct 2017 | WO |
| 2018098477 | May 2018 | WO |
| Entry |
|---|
| He, Kaiming, Georgia Gkioxari, Piotr Dollár, and Ross Girshick. “Mask r-cnn.” In Computer Vision (ICCV), 2017 IEEE International Conference on, pp. 2980-2988. IEEE, 2017. |
| U.S. Appl. No. 17/130,700, Dec. 22, 2020, Sarah Plewe. |
| U.S. Appl. No. 17/131,117, Dec. 22, 2020, Sarah Plewe. |
| Al-Ahmad et al., dated 2005, Early experience with a computerized robotically controlled cathetersystem, Journal of Interventional Cardiac Electrophysiology, 12:199-202, 4 pages. |
| Blankenstein, Jun. 2008, Dynamic Registration and High Speed Visual Servoing in Robot-Assisted Surgery, Katholieke Universiteit Leuven, Leuven, Belgium, 96 pages. |
| Ciuti et al., 2012, Intra-operative monocular 30 reconstruction for image-guided navigation in active locomotion capsule endoscopy. Biomedical Robotics And Biomechatronics (Biorob), 4th IEEE Ras & Embs International Conference On IEEE, 7 pages. |
| Darwiche, 2015, Operative technique and early experience for robotic assisted laparoscopic nephroureterectomy (RALNU) using da Vinci XI, SpringerPlus, 4:298, 5 pages. |
| Fallavollita et al., 2010, Acquiring multiview C-arm images to assist cardiac ablation procedures, EURASIP Journal on Image and Video Processing, vol. 2010, Article ID 871408, pp. 1-10. |
| Gutierrez et al., Mar. 2008, A practical global distortion correction method for an image intensifierbased x-ray fluoroscopy system, Med. Phys, 35(3):997-1007, 11 pgs. |
| Haigron et al., 2004, Depth-map-based scene analysis for active navigation in virtual angioscopy, IEEE Transactions on Medical Imaging, 23( 11 ): 1380-1390, 11 pages. |
| Hansen Medical, Inc. 2005, System Overview, product brochure, 2 pp., dated as available at http://hansenmedical.com/system.aspx on Jul. 14, 2006 (accessed Jun. 25, 2019 using the internet archive way back machine). |
| Hansen Medical, Inc. Bibliography, product brochure, 1 p., dated as available at http://hansenmedical.com/bibliography.aspx on Jul. 14, 2006 (accessed Jun. 25, 2019 using the internet archive wav back machine). |
| Hansen Medical, Inc. dated 2007, Introducing the Sensei Robotic Catheter System, product brochure, 10 pp. |
| Hansen Medical, Inc. dated 2009, Sensei X Robotic Catheter System, product brochure, 5 pgs. |
| Hansen Medical, Inc. Technology Advantages, product brochure, dated as available at http://hansenmedical.com/advantages.aspx on Jul. 13, 2006 (accessed Jun. 25, 2019 using the internet archive way back machine), 1 page. |
| International search report and written opinion dated Dec. 18, 2019 for PCT/US2019/53600 32836259, 13 pages. |
| Kiraly et al, 2002, Three-dimensional Human Airway Segmentation Methods for Clinical Virtual Bronchoscopy, Acad Radio!, 9:1153-1168, 16 pages. |
| Kiraly et al., Sep. 2004, Three-dimensional path planning for virtual bronchoscopy, IEEE Transactions on Medical Imaging, 23(9):1365-1379, 15 pages. |
| Konen et al., 1998, The VN-project: endoscopic image processing for neurosurgery, Computer Aided Surgery, 3:1-6, 6 pages. |
| Kukuk, Oct. 5, 2001, TBNA-protocols: Guiding TransBronchial Needle Aspirations Without a Computer in the Operating Room, MICCAI 2001, 2208:997-1006, 10 pages. |
| Kumar et al., 2014, Stereoscopic visualization of laparoscope image using depth information from 3D model, Computer methods and programs in biomedicine 113(3):862-868, 7 pages. |
| Lawton et al., 1999, Ribbons and groups: A thin rod theory for catheters and filaments, J. Phys. A., 1999, 32:1709-1735, 27 pages. |
| Livatino et al., 2015, Stereoscopic visualization and 3-D technologies in medical endoscopic teleoperation, IEEE, 11 pages. |
| Luo et al., 2010, Modified hybrid bronchoscope tracking based on sequential monte carlo sampler: Dynamic phantom validation, Asian Conference on Computer Vision. Springer, Berlin, Heidelberg, 13 pages. |
| Marrouche et al., dated May 6, 2005, AB32-1, Preliminary human experience using a novel robotic catheter remote control, Heart Rhythm, 2(5):S63. |
| Mayo Clinic, Robotic Surgery, https://www.mayoclinic.org/tests-procedures/robotic-surgery/about/pac-20394974?p=1, downloaded from the internet on Jul. 12, 2018, 2 pp. |
| Mourgues et al., 2002, Flexible calibration of actuated stereoscopic endoscope for overlay in robot 672 assisted surgery, International Conference on Medical Image Computing and Computer-Assisted Intervention. SprinQer, Berlin, HeidelberQ, 10 pages. |
| Nadeem et al., 2016, Depth Reconstruction and Computer-Aided Polyp Detection in Optical Colonoscopy Video Frames, arXiv preprint arXiv:1609.01329, 12 pages. |
| Oh et al., dated May 2005, P5-75, Novel robotic catheter remote control system: safety and accuracy in delivering RF Lesions in all 4 cardiac chambers, Heart Rhythm, 2(5):S277-S278, 2 pages. |
| Point Cloud, Sep. 10, 2010, Wikipedia, 2 pp. |
| Racadio et al., Dec. 2007, Live 3D guidance in the interventional radiology suite, AJR, 189:W357-W364, 8 pages. |
| Reddy et al., May 2005, P1-53. Porcine pulmonary vein ablation using a novel robotic catheter control system and real-time integration of CT imaging with electroanatomical mapping, Hearth Rhythm, 2(5):S121, 1 page. |
| Sasaki, 2017, Laparoscopic hemicolectomy for a patient with situs inversus totalis: a case report, Int. J. Surg. Case Rep. 41 :93-96, 4 pages. |
| Sato et al., 2016, Techniques of stapler-based navigational thoracoscopic segmentectomy using virtual assisted lung mapping (VAL-MAP), Journal of Thoracic Disease, 8(Suppl 9):S716, 15 pages. |
| Shen et al., 2015, Robust camera localisation with depth reconstruction for bronchoscopic navigation. International Journal of Computer Assisted Radiology and Surgery, 10(6):801-813, 13 pages. |
| Shi et al., Sep. 14-18, 2014, Simultaneous catheter and environment modeling for trans-catheter aortic valve implantation, IEEE/RSJ International Conference on Intelligent Robots and Systems, pp. 2024-2029, 6 pages. |
| Slepian, dated 2010, Robotic Catheter Intervention: the Hansen Medical Sensei Robot Catheter System, PowerPoint presentation, 28 pp. |
| Solheim et al., May 14, 2009, Navigated resection of giant intracranial meningiomas based on intraoperative 3D ultrasound, Acta Neurochir, 151 :1143-1151, 9 pages. |
| Solomon et al., Dec. 2000, Three-dimensional CT-Guided Bronchoscopy With a Real-Time Electromagnetic Position Sensor A Comparison of Two Image Registration Methods, Chest, 118(6):1783-1787, 5 pages. |
| Song et al., 2012, Autonomous and stable tracking of endoscope instrument tools with monocular camera, Advanced Intelligent Mechatronics (AIM), 2012 IEEE-ASME International Conference on. IEEE, 6 pages. |
| Vemuri et al., Dec. 2015, Inter-operative biopsy site relocations in endoluminal surgery, IEEE Transactions on Biomedical Engineering, Institute of Eleclrical and Electronics Engineers, < 10 .1109/T8ME 2015.2503981 >, 13 pages. |
| Verdaasdonk et al., Jan. 23, 2012, Effect of microsecond pulse length and tip shape on explosive bubble formation of 2.78 μm Er,Cr;YSGG and 2.94 μm Er:YAG laser, Proceedings of SPIE, vol. 8221. 12. |
| Verdaasdonk et al., Jan. 23, 2012, Effect of microsecond pulse length and tip shape on explosive bubble formation of 2.78 μm Er,Cr;YSGG and 2.94 μm Er:YAG laser, Proceedings of SPIE, vol. 8221, 12, 1 page. |
| Wilson et al., 2008, a buyer's guide to electromagnetic tracking systems for clinical applications, Proc. of SPCI, 6918:691828-1 p. 69188-11, 12 pages. |
| Yip et al., 2012, Tissue tracking and registration for image-guided surgery, IEEE transactions on medical imaging 31 (11 ):2169-2182, 14 pages. |
| Zhou et al., 2010, Synthesis of stereoscopic views from monocular endoscopic videos, Computer Vision and Pattern Recognition Workshops (CVPRW), 2010 IEEE Computer Society Conference on IEEE, 8 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20210196398 A1 | Jul 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62955991 | Dec 2019 | US |
